



























   Tetrodotoxin (TTX) was originally isolated from the puffer fish, Spheroides rubripes, and is 
responsible for its toxicity. TTX is a highly functionalized zwitterion with an ortho acid and a cyclic 
guanidine and hemiaminal. The structure of TTX was independently elucidated by Hirata-Goto, Tsuda, 
and Woodward in 1964 and the absolute stereochemistry was determined using X-ray by Nitta et al. in 
1970. TTX specifically inhibits voltage-dependent Na+ channels and has been widely used in 
neurophysiology and neuroscience. Significant efforts have been devoted to the total synthesis of TTX 
and its congeners. Since the first total synthesis of racemic TTX was reported by Kishi and Goto in 1972, 
several have been reported by Isobe and Nishikawa, Du Bois, and Sato. 
This thesis consists of 4 chapters. Chapter 1 describes the isolation, structure feature, and biological 
activities of TTX and its congeners, previous total synthesis and synthetic research of TTX, and our 
synthetic strategy for TTX. Chapter 2 involves a trial of Diels–Alder (DA) reaction using dehydroamino 
acid ester and furan derivatives. We expected that DA product with high oxidative level and multi 
functionalities might be obtained by a combination of these substrates in one step. Novel 
cyclopropanation reaction was also described. This reaction proceeded without catalysts and solvents to 
give a highly functionalized cyclopropane with nitrogen-containing quaternary carbon center as a single 
diastereomer. In Chapter 3, DA reaction of nitroolefin with substituted furan was described. This 
reaction proceeded in regio- and stereoselective manner to afford the DA product with 
oxabicyclo[2.2.1]heptane skeleton. Chapter 4 described the synthesis of the key intermediate with 
carbon skeleton equal to TTX from DA product. The quaternary amino carbon center at C8a position 
was stereoselectively constructed by Tsuji–Trost reaction established in a model experiment. The 






Ac  Acetyl 
Alloc  Allyloxycarbonyl 
Ar  aryl (substituted) 
Bn  Benzyl 
Boc   tert-butoxycarbonyl 
BOM  Benzyloxymethyl 
Bu  Butyl 
Bz  benzoyl 
calcd  calculated 
Cbz  benzyloxycarbonyl 
CI  chemical ionization 
CSA  10-camphorsulfonic acid 
dba  dibenzylideneacetone 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCE  1,2-dichloroethane 
DIBAL  diisobutylaluminium hydride 
DMAP  4-dimethylaminopyridine 
DMF  N,N-dimethylformamide 
DMP  Dess-Martin periodinane 
DMSO  dimethyl sulfoxide 
dr  diastereomeric ratio 
Et  ethyl 
Epi  epimer 
eq.  equivalent 
ESI  Electrospray ionization 
EWG  electron withdrawing group 
FAB  fast atom bombardment 
FTIR  fourier transform infrared spectroscopy 
HRMS  high-resolution mass spectrum 
i  iso- 
IBX  2-iodoxybenzoic acid 
Im  imidazole 
J  coupling constant (in NMR) 
KHMDS  potassium hexamethyldisilazide 
K-selectride potassium tri-sec-butylborohydride 
  
LDA  lithium diisopropylamide 
LHMDS  lithium hexamethyldisilazide 
M  molar 
m-CPBA  meta-chloroperbenzoic acid 
Me  methyl 
MOM  methoxymethyl 
Ms  methansulfonyl, mesyl 
MW  micro wave 
n  normal 
NMO  N-methylmorpholine N-oxide 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect 
Ns  2-nitrobenzenesulfonyl, nosyl 
PCC  Pyridinium ChloroChromate 
Ph  phenyl 
Phth  phtharoyl 
Piv  pivaloyl 
PPTS  pyridinium p-toluenesulfonate 
Py  pyridine 
rt  room temperature 
sec  secondary 
s.m.  starting material 
t, tert  tertiary 
TBAF  tetrabutylammonium fluoride 
TBDPS  tert-butyldiphenylsilyl 
TBS  tert-butyldimethylsilyl 
temp.  temperature 
TEMPO  2,2,6,6-tetramethylpiperidinyloxy, free radical 
TES  teriethylsilyl 
Tf  trifluoromethanesulfonyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TIPS  triisopropylsilyl 
TLC  thin-layer chromatography 
TMS  trimethylsilyl 
TPAP  tetrapropylammonium perruthenate 
TS  transition state 
  
Ts  para-toluenesulfonyl 
wt  weight 
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が根付いているため、TTX による食中毒がしばしば発生している。ヒトに対する TTX の致死
量は 2 mg であり、マウス 1 万匹の致死量に相当している。1)フグ毒に関する研究は 19 世紀後
半から開始され、最初の報告は 1895 年に遡る。田原らは 1909 年に毒成分を鉛塩として沈殿
させ硫化水素で脱鉛することによって、TTX を単離した。フグの学名 Tetraodontiformes にち
なんでテトロドトキシンと命名した。2)しかし、その複雑な構造や化学的不安定性から 1964
年まで構造決定にいたらなかった。津田、Woodward、Mosher らの 3 つの研究グループは、独
自に TTX の構造を報告した。3)絶対立体配置は 1970 年、仁田らによって X 線結晶構造解析で
決定された。4)TTX は東南アジアに生息しているフグだけでなく、オーストラリア沿岸のヒョ
ウモンダコ 5)、カリフォルニア産のイモリ 6)、台湾や奄美大島産のツムジハゼ 7)、コスタリカ
産のカエル 8)の他、巻き貝 (バイ貝、ボウシュウボラ貝)、ヒトデ (トゲモミジ貝)、エラコ (環









TTX はジオキサアダマンタン骨格に官能基が密集した特異な骨格中に含窒素 4 級炭素を含





























メント S1–S6 からなる 4 つのリピート構造で構成されている(Figure 1-2)。11)チャネル毒素の
結合位置により計 6 つの site が存在しており、site 2 に結合する化合物として veratridine, 
batrachotoxin, grayanotoxin、site 3 には-scorpion toxin, sea-anemone toxin, spider toxin が、site 4
には-scorpion toxin が、site 5 には brevetoxin, ciguatoxin が、site 6 に対しては-conotoxin が知
















TTX の類縁体が様々な生成物から単離されている(Figure 1-3)。以下に 2005 年までの単離例
を示す。4-epiTTX (2)、4,9-anhydroTTX (9)と Tetrodonic acid (11)の 3 種 13)、6-epiTTX (3)と 11-
deoxyTTX (4) 14)、11-oxoTTX (5) 15)、11-norTTX-(6S)-ol (6) 16)、11-norTTX-(6R)-ol (7) 17)、5,6,11-
-deoxyTTX (12) 18)が、日本産のコモンフグ Takifugu poecilonotus とヒガンフグ Takifugu pardalis
の肝臓、沖縄産のイモリ Cynops ensicanda、ミクロネア産のコクテンフグ Arothron 
nigropunctatus、沖縄産のコクテンフグ Arothron nigropunctatus、クサフグ Takifugu niphobles の
肝臓、下関産のコモンフグFugu poecilonotusの卵巣から安元らによってそれぞれ単離された。
この他にもコスタリカ産の矢毒蛙 Atelopus chiriquiensis の皮膚から TTX の 11 位に glycine が
3 
 
置換した Chiriquitoxin (8)が 19)、日本産のイモリ Cynops pyrrhogaster の皮膚から 6-epi-4,9-
anhydro (10)が 20)、イモリ Taricha granulosa から初の N-hydroxy 体である 1-Hydroxy-5,11-
dideoxyTTX (13)が 21)、コガネガエルBrachycephalidaeから5-deoxyTTX (14)が単離されている。




























































































































































た(Table 1-1)。類縁体 16–18 は TTX から誘導された非天然型のアナログである。水酸基が欠
落すると、活性は 10~20 分の 1 に低下した (entries 4, 6, 7)。また、オルソ酢酸エステルが開裂
すると活性は著しく低下した(11, 16)。さらに 6、11 位の 2 つの水酸基とオルソ酢酸エステル





らの報告とも一致している。26)水酸基の立体化学も重要であり、epi 体では 20~40 分の 1 に低
下した(entries 2, 3)。TTX-8-O-hemisuccinate (18)は約 400 分の 1 に活性が低下した。これはカ
ルボン酸側鎖がグアニジン部位と分子内で塩を形成することでナトリウムイオンチャンネル
とグアニジン部位との結合が阻害されたためと考えられている。いくつかの類縁体は TTX よ
りもやや強い活性を示し、いずれも 11 位が化学修飾を受けたものとなっている(entries 5, 8, 
17)。 
 






































































































K0 = the equilibrium dissociation constant for the interaction of TTX and its congeners with the 
rat synaptic membrane by measuring the decreasing concentration of [3H]STX binding to the Na+ 
ion channel 













 1972 年に後藤、岸らによって初めてラセミ体の TTX の全合成が達成された。27)それ以後、
多くの合成化学者たちによって光学活性体の全合成研究が行われた。その結果、約 30 年経過
した 2000 年代に磯辺、西川ら、Du Bois ら、そして佐藤らによって光学活性体の全合成が達
成された。以下にこれら 3 つの研究グループによる全合成、及びその他の合成研究例を示す。 
 
磯部、西川らの全合成 
 磯部、西川らは 2003 年に初の光学活性体の全合成を達成した。28)当時全合成は 70 段階以
上を要したが、2004 年に約 30 段階短縮した効率的合成を報告している。29)あわせて天然及び
非天然型の TTX 類縁体合成も数多く報告している。1999 年に 5,11-dideoxyTTX (19) 30)、2002
年に 8,11-dideoxyTTX (20) 31)、11-deoxyTTX (4) 32)、2014 年に 5-deoxyTTX (14)と 8-deoxyTTX 




























































Figure 1-4. Structures of deoxyTTXs 
 
Overmann 転位と Diels–Alder (DA)反応を鍵反応として、高い酸化段階を満足するシクロヘ
キセンクロロカーバメートへと導いている。Levoglucosenone から得られるブロモ体とブタジ
エンとの Diels–Alder 反応により、10 位を除く全ての炭素を満足するシクロヘキセン体を立体
選択的に合成した(Scheme1-1)。この際、Levoglucosenone の不斉が 4a 位に転写されている。
シクロヘキセン体から 5 段階を経て得られるアリルアルコール体に対して、炭酸カリウムを
用いる条件を適用することにより、Overmann 転位が進行し含窒素 4 級炭素を立体選択的に構




考察している。転位体の 3 置換オレフィンに対して臭素を付加させた後、DBU で処理するこ
とでアリルブロマイドの生成と分子内 SN2’反応によって 8 位に水酸基を導入した。続いて、






































































Scheme 1-1. Construction of cyclohexene core 
 
 続いて-ラクトンの構築を行っている(Scheme1-2)。二酸化セレンによるアリル位酸化によ
り 11 位に水酸基を導入し、続いて m-CPBA を用いた立体選択的なエポキシ化により、6 位の
4 級炭素を構築した。オゾン分解によりビニル基をアルデヒドへ変換した後に 10 位の C1 ユ
ニット等価体として、アルキンを導入した。酸化的開裂により得られたケトカルボン酸を塩
















































































除去を一挙に行うことで TTX (1)と 4,9-anhydroTTX (9)の全合成を達成した。 






























































































Scheme 1-3. Total synthesis of 1 
 
Du Bois らの全合成 34) 
 Du bois らは 2003 年に独自に開発したカルベンの C–H insertion 反応による 6 位と 8a 位の 2
つの 4級炭素の立体選択的な構築を鍵とした全合成を報告している(Scheme 1-4)。D-isoascorbic 
acid から誘導したアミド体を出発物質に用いて、アルドール反応とジアゾ化反応を含む 5 段
階で C–H insertion 前駆体を得た。Rh2(NHCOCPh3)4触媒存在下 C–H insertion 反応が進行し、6
位の 4 級炭素の立体化学を制御するとともにシクロヘキサン骨格を構築した。4 位の C1 ユニ
ット等価体と 5 位の水酸基の導入を行い、2 度目の C–H insertion 前駆体へと導いた。酸化剤





























































































































































Scheme 1-4. Du Bois’s total synthesis of 1 
 
佐藤らの全合成 
 2005 年に佐藤らは myo-inositol からラセミ体の 1 の全合成を報告している。35)また、2008 年
にはラセミ体の際の合成中間体を D-glucose から誘導することで、光学活性体の全合成も達成
している。36)さらに、2010 年に Petasis–Ferrier 転位を鍵とした効率的な全合成を報告してい
る。37)以下に改良全合成経路を示す。 
 1 の 6 位と 8a 位の 4 級炭素はエオキソオレフィンに対するエポキシ化と LiCHCl2のケトン
への付加によって立体選択的に構築している(Scheme 1-5)。既知の手法により D-glucose から
4 段階で誘導したケトン体を Peterson 反応に付すことで exo-オレフィン化した。m-CPBA を用
いたエポキシ化により、6 位の 4 級炭素の立体化学を制御するとともにジオールを構築後、
エノールエーテル化することで Petasis–Ferrier 転位前駆体を得た。Hg(OAc)2存在下、転位反応
が進行しシクロヘキサノン骨格の構築に成功している。Peterson 反応による 4 位の C1 炭素の




















































































Scheme 1-5. Construction of cyclohexanone core 
 
 次に 8a 位の含窒素 4 級炭素と 10 位の C1 ユニットを導入している(Scheme 1-6)。ケトン体
に対する LiCHCl2の付加後、クラウンエーテル存在下 NaN3と反応させることで含窒素 4 級炭
素を立体選択的に構築した。生じたアルデヒド体に対し、シアノ基を付加させることで 10 位










































































































P - P = acetonide







 2 度の分子内環化反応による、1 の-ラクトン部位に相当する 4a、5、8a、9 位の 4 連続不斉
中心の立体選択的構築を鍵とした合成研究を報告している(Scheme 1-7)。p-アニスアルデヒド
から数工程で誘導したカーバメート体のヨードアミノ環化反応により、8a 位の含窒素 4 級炭
素を立体選択的に構築している。続いて 8a 位の立体化学を利用した基質制御によるニトロ体




















































Scheme 1-7. Fukuyama’s synthetic research of 1 
 
Taber らの研究 39) 
 既知の 1,2,5,6-di-isopropylidene-D-mannitol をキラルな出発原料として用い、1 の 4a、5、6 位
に相当する立体化学を制御したシクロヘキセンノン体の合成を報告している(Scheme 1-8)。原
料から数段階で誘導したケトン体のアルキリデンカルベンの C–H 挿入反応に続く、環拡大反



















































































































Scheme 1-10. Alonso’s synthetic research of 1 
 





















































(Scheme 1-12)。22 は含窒素電子不足オレフィン 23 とフラン 24 との DA 反応により、理論上
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れた。TTX のシクロヘキサンコアには 4a 位、8a 位、6 位の 3 つの位置に酸素官能基をもつ炭





の 4 位、9 位の水酸基に相当する酸素官能基を化合物の生成が期待できる。10 位に相当する














































































酸エステルの合成を試みた。既知の方法 3)により合成した Horner–Wadsworth–Emmons (HWE)
試薬 25a をアミン体 26 に還元後、それぞれの条件により CHO 基と Phth 基へと窒素保護基
をかけ換えた HWE 試薬 25b、25c を合成した(Scheme 2-1)。合成した HWE 試薬 25a–c を用
いて所属研究室が開発した ZnCl2を添加剤として用いる条件を適用することで、種々のデヒ
ドロアミノ酸エステルを合成した(Table 2-1)。具体的には位、位にエステル基を持つデヒ
ドロアミノ酸エステル 27、28、29 (entries 1–3)、ヒドロキシメチル側鎖をもつ 30 (entry 4)、
,-ジ置換タイプの基質 31 (entry 5)および、位のエステル基を欠落させたデヒドロアラニン
体 32 を合成した(entry 6)。合成したデヒドロアミノ酸エステルに対して化学修飾を行うこと
でいくつかの基質にも誘導した(Scheme 2-2)。27 に対し Boc 化、N-アルキル化を行うことで
BocCbz 保護体 33、N-メチル体 34 を合成した。30 の TBS 基を除去し、長時間攪拌すること
















EtOCHO, ref lux, 2 h
phthalic anhydride (1.0 eq.), Et3N (1.0 eq.), CH2Cl2, rt, 13 h




25a 26 25b X = NHCHO
25c X = NPhth
 























































































CH2Cl2, rt, 15 min
91%
CO2Et
E : Z = 8.2 : 1
MeI (3.0 eq.)
K2CO3 (3.0 eq.)
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Scheme 2-2. Synthesis of dehydroamino acid esters 
 
モノ保護体を用いた DA 反応の試み 
 
まず、Cbz 基、CHO 基で保護したデヒドロアミノ酸エステル 27、28 とフランとの DA 反応
を試みた(Table 2-2)。しかしがなら、封管中大過剰量のフラン存在下、無溶媒で過熱する過酷
な条件を適用したが反応は全く進行しなかった(entry 1)。温度を 180 度まで昇温すると基質の
分解が観測された(entry 2)。ジエンの反応性を高めるために、電子供与性の置換基としてメチ




Table 2-2. DA reaction in thermal condition 
sealed tube, neat




























a This reaction was performed at 180 oC.
27 P = Cbz
28 P = CHO
 
 
 DA 反応は LA により反応が加速することや選択性が向上することが知られている。そこ
で、27、28 に対して CH2Cl2 中過剰量のフラン存在下、様々な LA を用いて反応を試みたが、




CH2Cl2, rt, 1823 h
furan (5.0 eq.)
LA (1.0 eq.)





27 P = Cbz
28 P = CHO
 
Scheme 2-3. DA reaction in LA condition 
 
 次にデヒドロアミノ酸エステル側の保護基や置換基を改変することによる反応性の向上を
狙った(Scheme 2-4)。具体的には、電子吸引基として窒素原子上に Boc 基を導入した基質
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デヒドロアミノ酸エステル 27 に対して、LA として TMSOTf を用いた場合は望む DA 反応




CbzHN furan (5.0 eq.)
TMSOTf (1.0 eq.)













Scheme 2-5. Aromatic electrophilic substitution reaction 
 
反応機構を探る目的で保護基の異なるデヒドロアミノ酸エステルに対して反応を試みたと
ころ、CHO 保護した基質 28 は反応が進行し、フラニル体 37 を 40%で与えた(Table 2-3)。一
方、N-メチル化体 34、Phth 体 29 では反応は進行しなかった。β 位のエステル基を欠落させた
基質 32 では複雑な混合物を与えた。これらの結果は先のイミニウムイオン中間体の存在を示









































Cbz 基で保護したデヒドロアミノ酸エステル 27、28 は反応が進行しなかった(entries 1 and 2)。





























Phth 体を用いた DA 反応の試み 
 
先の結果をふまえ、29 を用いて、再びフランとの DA 反応を試みた(Scheme 2-6)。しかしな
がら、各種フラン存在下加熱及び LA 条件においてともに反応は進行しなかった。立体的に













CH2Cl2, rt, 2022 h
LA (1.0 eq.)














no reaction Me2AlCl (1.0 eq.), CH2Cl2, rt, 20 h




















Phth 体 29 に対して 2-メトキシフラン存在下無溶媒で封管中 120 度に加熱すると、驚くべ
きことにシクロプロパン化反応が進行し、含窒素 4 級炭素を有するアミノシクロプロパン









































シンは低血糖を引き起こすとともにネズミチフス菌 TA 100 の自然突然変異を阻害すること






















dr = 96 : 4




















 3 位にアルキル側鎖を有するフランの合成を試みた(Table 2-5)。既知の手法を参考に 3-ブロ
モフラン 40 に対して n-BuLi 存在下求電子剤と反応させることで 3 位に Et 基、n-Bu 基、allyl
基を導入したラクトン体 41a–c を得た。11)続いて、Et3N 存在下 TIPSOTf と反応させることで


























































oC to rt, 2 h
81%
41d Ar = Ph: 37%
41e Ar = p-MeOPh: 18%
42d Ar = Ph: 81%
42e Ar = p-MeOPh: 92%
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2-9)。Cbz 基で保護したモノ保護体 27 や Me 基を導入した基質 34 ではシクロプロパン体の
生成は観測されなかった。この原因としては窒素原子からオレフィンへの電子供与により、
2-メトキシフランに対する反応性が低下したことが考えられる。また、位のメチルエステ



























Scheme 2-9. Cyclopropanation reaction using dehydroamino acid ester derivatives 
 
 2-メトキシフランは原料合成が容易かつ大量に供給可能な 2-シロキシフラン 13)の代用が可
能であり、62%収率でシクロプロパン体 45a を与えた(Table 2-6, entry 1)。これにより、生成物
の 3 つのエステル基を差別化できた。次に置換基を導入したフランを用いて反応を試みた。
3 位にメチル基をもつメチルフラン 13)では反応が進行し、47%収率でシクロプロパン体 45b を
与えた(entry 2)。この他にも Et 基、n-Bu 基、allyl 基や芳香環を有する基質 42a–e も適用でき、




















































































































































neat, rt, 21 h
cat. = RhCl(PPh3)3, [Rh(OCOCPh3)2]2,
CuCl, Cu(OAc)2, Cu(acac)2
s.m. + complex mixture
29
 
Scheme 2-11. Trapping of carbene intermediate by addition of metal catalysts 
 
推定反応機構を示した(Scheme 2-12)。2 段階の反応機構を想定している。すなわち、デヒド
ロアミノ酸エステル 29 に対し立体的にすいた β 位でフランが求核攻撃したのち(A, B)、エノ
ラートからフラノンへ分子内 SN2 反応を起こすことで生成物が得られたと考えられる。立体
化学は二段階目の SN2 反応における遷移状態の安定性によって決まると考えられる。想定さ
れる 4 つの配座(C–F)のうち 1,3-allylic strain の反発が小さい C、E を経る経路が有利であると
考えられる。E から反応が進行した場合は立体反発の大きい置換基がオール cis 配置の生成物













































































Scheme 2-12. Proposed reaction mechanism of cyclopropanation 
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で述べるニトロオレフィンを用いた DA 反応においては 2 置換タイプの基質を使った、含窒




















述べた。種々の基質に対して、過酷な加熱条件および LA 条件を適用したが望む DA 生成物
を得るにはいたらなかった。シクロプロパン化反応の基質一般性を調査した結果、Phth 基と



































All reagents and solvents were obtained from either Aldrich Chemical Company, Inc., Merck 
& Co., Inc., Nacalai Tesque Company, Ltd., Tokyo Kasei, Kogyo Co., Ltd, Kanto Chemical Co., Ltd., 
Peptide Institute Inc., and used without further purification unless otherwise indicated. Dichloromethane 
(CH2Cl2) was distilled from diphosphorus pentaoxide (P2O5). Tetrahydrofuran (THF), diethyl ether 
(Et2O) and dimethylformamide (DMF) of anhydrous grade were used. FTIR spectra were measured on 
a JASCO FT-IR 420 or 6200 infrared spectrophotometer. 1H NMR spectra were recorded on an either 
JEOL JNM-LA 400 (400 MHz), Bruker AVANCE 600 (600 MHz), or Bruker AVANCE 300 (300 MHz) 
spectrometer at ambient temperature. Chemical shifts of 1H NMR were reported in parts per million 
(ppm, ) relative to CHCl3 = 7.26) in CDCl3, CD2HOD = 3.30) in CD3OD. 13C NMR spectra were 
recorded on an either JEOL JNM-LA 400 (100 MHz), Bruker AVANCE 600 (150 MHz), or Bruker 
AVANCE 300 (75 MHz) spectrometer. Chemical shifts of 13C NMR were reported in ppm () relative 
to CDCl3 (= 77.0) and CD3OD (= 49.0). Low resolution mass spectra (LRMS) and high resolution 
mass spectra (HRMS) were measured on a JEOL JMS-AX500 for fast atom bombardment ionization 
(FAB), chemical ionization (CI), electron ionization (EI) or Bruker solariX XR (9.4T) for electrospray 
ionization (ESI). All reactions were monitored by thin layer chromatography (TLC), which was 
performed with precoated plates (Merck Kieselgel 60 F-254, 0.25 mm). TLC visualization was 
accomplished using UV lamp (254 nm) or a charring solution (ethanoic molybdophosphoric acid). 





Experimental Section for Chapter 2. 
 






To a solution of 25a (9.93 g, 30.0 mmol) in MeOH (150 mL) was added Pd/C (10 wt%, 993 
mg). The reaction mixture was stirred at room temperature for 3 h under H2 and filtered through a thin 
celite pad to remove Pd/C. The filtrate was concentrated in vacuo to give the corresponding amine 26 
which was subjected to the next step without purification. A solution of 26 (1.49 g, 7.58 mmol) in ethyl 
formate (22 mL) was refluxed for 1 h and concentrated in vacuo to give 25b (1.47 g, 86%) as a yellow 
solid, whose spectral data were identical with those of the authentic data.15) 
 






To a solution of 26 (2.89 g, 14.7 mmol) in CH2Cl2 (30 mL) were added phthalic acid anhydrous 
(2.18 g, 14.7 mmol) and Et3N (2.05 mL, 14.7 mmol) under an Ar atmosphere. The reaction mixture was 
stirred at room temperature for 13 h, and then Ac2O (2.91 mL, 29.4 mmol), Et3N (2.05 mL, 14.7 mmol) 
and DMAP (180 mg, 1.47 mmol) were added. The mixture was stirred for 10 h. Sat. NH4Cl was added 
to the mixture, which was extracted with AcOEt. The combined organic layer was washed with NaHCO3 
and brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo to give 25c (3.85 g, 
80%) as a yellow solid; 
1H NMR (400 MHz, CDCl3) δ 7.90 (dd, J = 5.6, 3.2 Hz, 2 H), 7.76 (dd, J = 5.6, 3.2 Hz, 2 H), 5.43 (d, J 
= 24.6 Hz, 1 H), 3.93 (d, J = 11.2 Hz, 3 H), 3.88 (d, J = 10.5 Hz, 3 H), 3.84 (s, 3 H); 
13C NMR (75 MHz, CDCl3) δ 166.3 (d, 3JCP = 1.5 Hz), 164.6 (d, 2JCP = 3.8 Hz), 134.3, 131.6, 123.7, 
54.6 (d, 2JCP = 6.0 Hz), 53.7 (d, 2JCP = 6.0 Hz), 53.4, 49.1 (d, 1JCP = 156.8 Hz); 
FTIR (neat) 2356, 1754, 1724, 1390, 1264, 1035, 716 cm-1; 
HRMS (FAB) m/z calcd for C13H15NO7P (M+H)+ 328.0586, found 328.0605. 
 
General Procedure for the synthesis of dehydroamino acid ester: 
To a solution of HWE (1.0 eq.) in THF (0.1 M) was added ZnCl2 (1.0 M solution in Et2O, 2.0 
eq.) and DBU (1.0 eq.) at 0 oC under an Ar atmosphere. The reaction mixture was stirred for 30 min and 
then an electrophile (1.0 eq.) was added. The mixture was stirred at room temperature for over night. 
Sat. NH4Cl was added to the mixture, which was extracted with AcOEt. The combined organic layer 
was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The E/Z 
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crude mixture was separated by flash column chromatography on silica gel to the desired (E)-product. 
 





Following the general procedure, the reaction of ethyl glyoxalate (50% in toluene, 4.02 mL, 
20.3 mmol) with ZnCl2 (40.6 mL, 40.6 mmol), DBU (3.04 ml, 20.3 mmol) and 25a (6.72 g, 20.3 mmol) 
afforded 27 (4.49 g, 72%) as a yellow solid; 
1H NMR (300 MHz, CDCl3) δ 7.35 (m, 5 H), 7.10 (brs, 1 H), 6.43 (brs, 1 H), 5.14 (s, 2 H), 4.17 (q, J = 
7.1 Hz, 2 H), 3.84 (s, 3 H), 1.26 (t, J = 7.1 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 166.1, 163.7, 152.1, 137.4, 135.0, 128.6, 128.6, 128.4, 105.8, 67.9, 60.8, 
53.2, 14.1; 
FTIR (neat) 3299, 3035, 1744, 1627, 1534, 1209, 1150, 1035, 746 cm-1; 
HRMS (FAB) m/z calcd for C15H18NO6 (M+H)+ 308.1134, found 308.1135. 
 





Following the general procedure, the reaction of ethyl glyoxalate (50% in toluene, 1.13 mL, 
5.70 mmol) with ZnCl2 (11.5 mL, 11.5 mmol), DBU (0.86 ml, 5.7 mmol) and 25b (1.28 g, 5.70 mmol) 
afforded 28 (951 mg, 83%) as a yellow solid; 
1H NMR (400 MHz, CDCl3) δ 8.39 (s, 1 H), 7.55 (brs, 1 H), 7.29 (s, 1 H), 4.23 (q, J = 7.3 Hz, 2 H), 3.87 
(s, 3 H), 1.30 (t, J = 7.3 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 163.9, 163.8, 159.6, 135.3, 109.5, 61.0, 53.2, 14.0; 
FTIR (neat) 3014, 1743, 1718, 1629, 1371, 1218, 1157 cm-1; 
HRMS (EI) m/z calcd for C8H11NO5 (M)+ 201.0637, found 201.0629. 
 





Following the general procedure, the reaction of ethyl glyoxalate (50% in toluene, 2.62 mL, 
13.2 mmol) with ZnCl2 (26.4 mL, 26.4 mmol), DBU (1.97 ml, 13.2 mmol) and 25c (4.32 g, 13.2 mmol) 
afforded 29 (3.24 g, 81%) as a yellow solid; 
1H NMR (400 MHz, CDCl3) δ 7.91 (dd, J = 5.6, 3.2 Hz, 2 H), 7.79 (dd, J = 5.6, 3.2 Hz, 2 H), 6.70 (s, 1 
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H), 4.24 (q, J = 7.1 Hz, 2 H), 3.89 (s, 3 H), 1.31 (t, J = 7.1 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 165.2, 164.3, 162.8, 135.1, 133.2, 131.1, 124.2, 118.1, 61.3, 53.0, 14.0; 
FTIR (neat) 2989, 1733, 1628, 1370, 1258, 1176, 714 cm-1; 
HRMS (EI) m/z calcd for C15H13NO6 (M)+ 303.0743, found 303.0745. 
 
Methyl (E)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butyldimethylsilyl)oxy)but-2-enoate (30) 
CO2MeCbzHN
OTBS  
Following the general procedure, the reaction of aldehyde16) (99.2 mg, 0.570 mmol) with ZnCl2 
(1.15 mL, 1.15 mmol), DBU (85 μL, 0.570 mmol) and 25a (262 mg, 0.570 mmol) afforded 30 (160 mg, 
74%) as a yellow solid; 
1H NMR (300 MHz, CDCl3) 7.37 (m, 5 H), 6.97 (brs, 1 H), 6.84 (brs, 1 H), 5.15 (s, 2 H), 4.68 (d, J = 
5.1 Hz , 2 H), 3.81 (s, 3 H), 0.91 (s, 9 H), 0.08 (s, 6 H); 
13C NMR (75 MHz, CDCl3) δ 163.6, 153.3, 135.9, 128.5, 128.2, 128.1, 122.9, 115.3, 66.9, 60.9, 52.4, 
25.8, 18.2, −5.3; 
FTIR (neat) 3406, 2954, 2929, 2857, 1732, 1709, 1518, 1346, 1251, 1214, 1082, 1038, 836, 752 cm-1; 
HRMS (ESI) m/z calcd for C19H29NNaO5Si (M+Na)+ 402.1713, found 402.1710. 
 





Following the general procedure, the reaction of diethyl 2-oxomalonate (0.46 mL, 3.00 mmol) 
with DBU (0.45 ml, 3.00 mmol) and 25a (993 mg, 3.00 mmol) afforded 31 (899 mg, 79%) as a yellow 
solid; 
1H NMR (400 MHz, CDCl3) δ 7.36 (m, 5 H), 5.18 (s, 2 H), 4.24 (m, 4 H), 3.87 (s, 3 H), 1.29 (m, 6 H); 
13C NMR (100 MHz, CDCl3) δ 166.5, 164.0, 162.5, 151.5, 147.6, 134.5, 128.7, 128.6, 128.5, 104.1, 
68.6, 61.8, 61.7, 53.1, 13.9, 13.8; 
FTIR (neat) 2899, 1751, 1684, 1605, 1457, 1252, 1198, 1054, 1028 cm-1; 
HRMS (EI) m/z calcd for C18H21NO8 (M+H)+ 379.1267, found 379.1270. 
 
Methyl 2-(((benzyloxy)carbonyl)amino)acrylate (32) 
CO2MeCbzHN
 
Following the general procedure, the reaction of (CH2O)n (25.5 mg, 0.850 mmol) with ZnCl2 
(340 μL, 0.340 mmol), DBU (25 μL , 0.170 mmol) and 25a (56.3 mg, 0.170 mmol) afforded 32 (39.2 
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mg, 98%) as a yellow solid, whose spectral data were identical with those of the authentic data. 17) 
 





To a solution of 27 (1.11 g, 3.60 mmol) in CH2Cl2 (11 mL) were added Boc2O (1.2 mL, 5.40 
mmol) and DMAP (44.0 mg, 0.360 mmol). The mixture was stirred at room temperature for 17 h. Sat. 
NH4Cl was added to the mixture, which was extracted with AcOEt. The combined organic layer was 
washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The E/Z 
crude mixture was separated by flash column chromatography on silica gel (hexane/AcOEt = 5 : 1) to 
give the desired (E)-33 (1.07g, 74%) as a yellow solid; 
1H NMR (400 MHz, CDCl3) δ 7.31 (m, 5 H), 6.82 (s, 1 H), 5.20 (s, 2 H), 4.11 (q, J = 7.1 Hz, 2 H), 3.74 
(s, 3 H), 1.45 (s, 9 H), 1.21 (t, J = 7.1 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 164.0, 162.5, 151.4, 149.5, 134.8, 134.3, 128.5, 128.4, 128.3, 128.0, 
84.5, 68.7, 61.5, 52.5, 27.7, 13.9; 
FTIR (neat) 2984, 1804, 1735, 1370, 1348, 1256, 1155, 1114, 1030 cm-1; 
HRMS (FAB) m/z calcd for C20H26NO8 (M+H)+ 408.1658, found 408.1658. 
 





To a solution of 27 (33.8 mg, 0.110 mmol) in DMF (0.55 mL) were added K2CO3 (45.6 mg, 
0.330 mmol) and MeI (21μL, 0.330 mmol). The mixture was stirred at room temperature for 2.5 h. Sat. 
NH4Cl was added to the mixture, which was extracted with Et2O. The combined organic phase was 
washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue 
was purified by flash column chromatography on silica gel (hexane/AcOEt = 5 : 1) to give 9c (32.5 mg, 
92%) as a yellow oil; 
1H NMR (400 MHz, CDCl3) δ 7.36 (m, 5 H), 5.45 (s, 1 H), 5.17 (s, 2 H), 4.16 (q, J = 7.1 Hz, 2 H), 3.70 
(s, 3 H), 3.22 (s, 3 H), 1.26 (t, J = 7.1 Hz, 3 H); 
13C NMR (75 MHz, CDCl3) δ 164.8, 164.1, 152.6, 146.7, 134.4, 128.3, 128.2, 128.1, 104.1, 68.8, 60.2, 
52.2, 34.6, 13.8; 
FTIR (neat) 2970, 1804, 1736, 1370, 1351, 1258, 1230, 1217, 1109 cm-1; 









To a solution of 32 (917 mg, 2.42 mmol) in THF (5 mL) were added AcOH (208 L, 3.63 
mmol) and TBAF (3.14 mL, 3.14 mmol, 1.0 M solution in THF) at 0 oC. The reaction mixture was stirred 
at room temperature for 23 h. Sat. NH4Cl was added to the mixture, which was extracted with AcOEt. 
The combined organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexane/AcOEt = 5 : 1) to give 35 (521 mg, 92%) as a colorless oil; 
1H NMR (300 MHz, CDCl3) 7.38 (m, 5 H), 7.20 (brs, 1 H), 6.98 (brs, 1 H), 5.22 (s, 2 H), 4.89 (d, J = 
1.8 Hz , 2 H); 
13C NMR (75 MHz, CDCl3) δ 169.6, 153.0, 135.3, 128.6, 128.5, 128.1, 125.9, 122.9, 70.1, 67.7; 
FTIR (neat) 3324, 3121, 3067, 2933, 1756, 1729, 1661, 1551, 1356, 1321, 1220, 1042, 764, 726 cm-1; 
HRMS (ESI) m/z calcd for C12H11NNaO4 (M+Na)+ 256.0586, found 256.0582. 
 




To a solution of 27 (36.8 mg, 0.120 mmol) and furan (0.044 ml, 0.600 mmol) in CH2Cl2 (0.6 
mL) was added TMSOTf (0.021 ml, 0.12 mmol) at 0 oC under an Ar atmosphere. The reaction mixture 
was stirred at room temperature for 4 h. Sat. NaHCO3 was added to the mixture, which was extracted 
with AcOEt. The combined organic layer was washed with brine, dried over MgSO4, and filtered. The 
filtrate was concentrated in vacuo. The residue was purified by flash column chromatography on silica 
gel (hexane/AcOEt = 5 : 1) to give 36 (19.8 mg, 44%) as a yellow oil; 
1H NMR (400 MHz, CDCl3) δ 7.34 (m, 5 H), 6.49 (s, 1 H), 6.34 (s, 2 H), 5.07 (d, J = 12.2 Hz, 1 H), 
5.02 (d, J = 12.2 Hz, 1 H), 4.11 (q, J = 7.1 Hz, 2 H), 3.87 (d, J = 17.2 Hz, 1 H), 3.76 (s, 3 H), 3.48 (d, J 
= 17.2 Hz, 1 H), 1.20 (t, J = 7.1 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 169.8, 169.7, 154.0, 150.3, 142.4, 136.1, 128.5, 128.4, 128.0, 110.8, 
107.7, 66.6, 60.9, 59.3, 53.6, 37.8, 13.9; 
FTIR (neat) 3414, 1738, 1497, 1290, 1249, 1196, 1042, 751 cm-1; 
HRMS (EI) m/z calcd for C19H21NO7 (M)+ 375.1318, found 375.1306. 
 






To a solution of 28 (112 mg, 0.560 mmol) and furan (203 μL, 2.79 mmol) in CH2Cl2 (1.1 mL) 
was added TMSOTf (101 μL, 0.560 mmol) at 0 oC under an Ar atmosphere. The reaction mixture was 
stirred at room temperature for 4 h. Sat. NaHCO3 was added to the mixture, which was extracted with 
AcOEt. The combined organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate 
was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexane/AcOEt = 1 : 1) to give 37 (60.1 mg, 40%) as a yellow oil; 
1H NMR (300 MHz, CDCl3) δ 8.17 (d, J = 1.5 Hz, 1 H), 7.35 (t, J = 1.2 Hz, 1 H), 7.18 (brs, 1 H), 6.36 
(d, J = 1.2 Hz, 1 H), 4.13 (q, J = 7.2 Hz, 2 H), 4.02 (d, J = 16.8 Hz, 1 H), 3.78 (s, 3 H), 3.53 (d, J = 16.8 
Hz, 1 H), 1.25 (t, J = 7.2 Hz, 3 H); 
13C NMR (75 MHz, CDCl3) δ 169.7, 169.6, 159.9, 149.5, 142.4, 110.7, 107.7, 60.9, 58.8, 53.6, 37.5, 
13.9; 
FTIR (neat) 3365, 2984, 2957, 1735, 1685, 1497, 1438, 1375, 1347, 1282, 1218, 1154, 1023, 757 cm-1; 








A mixture of 29 (20.0 mg, 66 μmol) and 2-methoxyfuran (247 μL, 2.64 mmol) in a sealed tube 
was heated at 120 oC. After 20 h, the reaction mixture was cooled to room temperature, then it was 
purified by flash column chromatography on silica gel (hexane/AcOEt = 5 : 1) to give 39 (14.8 mg, 
56%) as a yellow oil; 
1H NMR (300 MHz, CDCl3) δ7.87 (m, 1 H),7.82 (m, 1 H),7.74 (m, 2 H), 6.33 (dd, J = 11.4, 8.8 Hz, 1 
H), 6.07 (d, J = 11.4 Hz, 1 H), 4.41 (t, J = 8.8 Hz, 1 H), 4.11 (q, J = 7.2 Hz, 2 H), 3.76 (s, 3 H), 3.71 (s, 
3 H), 3.14 (d, J = 8.8 Hz, 1 H), 1.21 (t, J = 7.2 Hz, 3 H); 
13C NMR (75 MHz, CDCl3) δ 167.4, 167.0, 166.0, 139.4, 134.3, 134.2, 124.0, 123.8, 123.5, 61.6, 53.5, 
51.4, 42.8, 34.1, 32.6, 13.9; 
FTIR (neat) 2954, 1719, 1394, 1271, 1198, 753 cm-1; 
HRMS (EI) m/z calcd for C20H19NO8 (M)+ 401.1111, found 401.1104. 
 
General Procedure for the synthesis of furans: 
To a solution of furanone (1.0 eq.) in CH2Cl2 (1.0 M) were added Et3N (3.0 eq.) and TIPSOTf 
(1.2 eq.) at 0 oC. The mixture was stirred at room temperature for 2 h. Sat. NaHCO3 was added to the 
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mixture, which was extracted with AcOEt. The combined organic layer was washed with brine, dried 
over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue was purified by flash 





Following the general procedure, the reaction of 41a (518 mg, 4.62 mmol) with Et3N (1.94 
mL, 13.9 mmol) and TIPSOTf (1.49 mL, 5.54 mmol) afforded 42a (991 mg, 80%) as a colorless oil; 
1H NMR (400 MHz, CDCl3) 6.74 (m, 1 H), 6.15 (m, 1 H), 2.28 (m, 2 H), 1.25 (m, 3 H), 1.10 (m, 21 
H)
13C NMR (75 MHz, CDCl3) 152.2, 130.5, 112.0, 97.9, 17.5, 16.8, 14.4, 12.4; 
FTIR (neat) 2944, 2867, 1646, 1520, 1464, 1413, 1254, 997, 882, 670 cm-1; 





Following the general procedure, the reaction of 41b (626 mg, 4.47 mmol) with Et3N (1.87 
mL, 13.4 mmol) and TIPSOTf (1.44 mL, 5.36 mmol) afforded 42b (900 mg, 68%) as a colorless oil, 





Following the general procedure, the reaction of 41c (257 mg, 2.07 mmol) with Et3N (866 μL, 
6.21 mmol) and TIPSOTf (667 μL, 2.48 mmol) afforded 42c (441 mg, 76%) as a colorless oil; 
1H NMR (400 MHz, CDCl3) 6.75 (d, J = 2.2 Hz, 1 H), 6.13 (d, J = 2.2 Hz, 1 H), 5.87 (ddt, J = 6.4, 
10.0, 16.8 Hz, 1 H), 5.05 (dq, J = 16.8, 1.6 Hz, 1 H), 4.98 (dq, J = 10.0, 1.6 Hz, 1 H), 3.02 (dt, J = 6.4, 
1.6 Hz, 2 H), 1.26 (m, 3 H), 1.10 (d, J = 7.2 Hz, 18 H)
13C NMR (100 MHz, CDCl3) 152.8, 137.1, 130.1, 114.6, 112.7, 94.1, 28.1, 17.6, 12.4; 
FTIR (neat) 2946, 2869, 1648, 1521, 1410, 1250, 1070, 995, 883, 687 cm-1; 







Following the general procedure, the reaction of 41d (235 mg, 1.47 mmol) with Et3N (615 μL, 
4.4 mmol) and TIPSOTf (473 μL, 1.76 mmol) afforded 42d (376 mg, 81%) as a yellow oil; 
1H NMR (400 MHz, CDCl3) 7.61 (d, J = 7.5 Hz, 2 H), 7.33 (t, J = 7.5 Hz, 2 H), 7.14 (t, J = 7.5 Hz, 1 
H), 6.85 (d, J = 2.2 Hz, 1 H), 6.60 (d, J = 2.2 Hz, 1 H), 1.33 (m, 3 H), 1.11 (d, J = 7.2 Hz, 18 H)
13C NMR (75 MHz, CDCl3)  153.0, 133.2, 131.4, 128.3, 125.4, 124.9, 110.5, 97.4, 17.6, 12.4; 
FTIR (neat) 2946, 2868, 1619, 1530, 1412, 1233, 1146, 1055, 979, 883, 838, 764, 692 cm-1; 





Following the general procedure, the reaction of 41e (146 mg, 0.770 mmol) with Et3N (322 
μL, 2.31 mmol) and TIPSOTf (247 μL, 0.924 mmol) afforded 42e (245 mg, 92%) as a yellow oil; 
1H NMR (300 MHz, CDCl3) 7.52 (d, J = 8.9 Hz, 2 H), 6.89 (d, J = 8.9 Hz, 2 H), 6.83 (d, J = 2.4 Hz, 
1 H), 6.54 (d, J = 2.4 Hz, 1 H), 3.82 (s, 3 H), 1.30 (m, 3 H), 1.09 (d, J = 7.4 Hz, 18 H)
13C NMR (75 MHz, CDCl3)  157.1, 152.3, 131.2, 126.5, 125.9, 113.8, 110.5, 97.1, 55.2, 17.6, 12.4; 
FTIR (neat) 2944, 2866, 1631, 1517, 1247, 980, 883, 830, 668 cm-1; 
HRMS (EI) m/z calcd for C20H30O3Si (M)+ 346.1964, found 346.1965. 
 
General Procedure for the synthesis of cyclopropane: 
A mixture of dehyrdroamino acid ester (1.0 eq.) and 2-siloxyfuran (10 eq.) in a sealed tube 
was heated at 120 oC. After 19–21 h, the reaction mixture was cooled to room temperature, then it was 








Following the general procedure, the reaction of 29 (36.4 mg, 0.120 mmol) with 2-siloxyfuran 
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(288 mg, 1.20 mmol) afforded 45a (41.5 mg, 62%) as a yellow oil; 
1H NMR (300 MHz, CDCl3) δ7.83 (m, 2 H),7.73 (m, 2 H), 6.29 (dd, J = 11.4, 8.7 Hz, 1 H), 6.08 (d, J 
= 11.4 Hz, 1 H), 4.30 (t, J = 8.7 Hz, 1 H), 4.09 (q, J = 7.2 Hz, 2 H), 3.69 (s, 3 H), 3.11 (d, J = 8.7 Hz, 1 
H), 1.31 (m, 3 H), 1.20 (t, J = 7.2 Hz, 3 H), 1.07 (d, J = 7.2 Hz, 18 H); 
13C NMR (75 MHz, CDCl3) δ 167.4, 167.0, 165.2, 138.5, 134.2, 134.1, 126.2, 123.6, 123.5, 61.5, 53.5, 
42.6, 34.0, 32.8, 17.7, 13.9, 11.9; 
FTIR (neat) 2951, 2871, 1730, 1398, 1273, 1202, 721 cm-1; 








Following the general procedure, the reaction of 29 (30.3 mg, 0.100 mmol) with 2-siloxy-3-
methylfuran (254 mg, 1.00 mmol) afforded 45b (26.2 mg, 47%) as a colorless oil; 
1H NMR (400 MHz, CDCl3) 7.85 (m, 1 H),7.80 (m, 1 H),7.73 (m, 2 H), 6.03 (dd, J = 9.0, 1.2 Hz, 1 
H), 4.09 (dd, J = 9.0, 8.4 Hz, 1 H), 4.09 (q, J = 7.2 Hz, 2 H), 3.71 (s, 3 H), 3.06 (d, J = 8.4 Hz, 1 H), 
2.01 (s, 3 H), 1.34 (m, 3 H), 1.20 (t, J = 7.2 Hz, 3 H), 1.08 (dd, J = 7.6, 1.6 Hz, 18 H)
13C NMR (75 MHz, CDCl3)  167.8, 167.2, 166.8, 134.3, 134.2, 134.1, 131.8, 123.6, 123.5, 61.4, 53.4, 
42.6, 33.9, 33.7, 21.5, 17.8, 13.9, 11.9; 
FTIR (neat) 2948, 2869, 1730, 1408, 1273, 1175, 884, 721 cm-1; 








Following the general procedure, the reaction of 29 (22.1 mg, 73.0 μmol) with 42a (196 mg, 
0.730 mmol) afforded 45c (20.9 mg, 50%) as a colorless oil; 
1H NMR (400 MHz, CDCl3) 7.85 (m, 1 H),7.81 (m, 1 H),7.73 (m, 2 H), 5.98 (d, J = 8.8 Hz, 1 H), 
4.08 (q, J = 6.8 Hz, 2 H), 4.00 (dd, J = 8.8, 8.0 Hz, 1 H), 3.71 (s, 3 H), 3.06 (d, J = 8.0 Hz, 1 H), 2.39 
(m, 2 H), 1.34 (m, 3 H), 1.21 (t, J = 6.8 Hz, 3 H), 1.09 (m, 21 H)
13C NMR (100 MHz, CDCl3) 167.8, 167.2, 166.8, 140.4, 134.2, 134.1, 130.1, 124.8, 123.6, 61.4, 53.3, 
42.6, 34.0, 33.7, 28.1, 17.8, 13.9, 13.3, 12.0; 
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FTIR (neat) 2948, 2869, 1732, 1409, 1274, 1231, 771, 722 cm-1; 








Following the general procedure, the reaction of 29 (20.0 mg, 66 μmol) with 42b (196 mg, 
0.660 mmol) afforded 45d (21.8 mg, 55%) as a colorless oil; 
1H NMR (400 MHz, CDCl3) 7.84 (m, 1 H),7.80 (m, 1 H),7.72 (m, 2 H), 5.97 (d, J = 8.8 Hz, 1 H), 
4.08 (q, J = 7.2 Hz, 2 H), 3.98 (dd, J = 8.8, 8.0 Hz, 1 H), 3.71 (s, 3 H), 3.06 (d, J = 8.0 Hz, 1 H), 2.34 
(m, 2 H), 1.46 (m, 2 H), 1.34 (m, 5 H), 1.21 (t, J = 7.2 Hz, 3 H), 1.09 (d, J = 7.6 Hz, 18 H)0.90 (t, J = 
7.6 Hz, 3 H)
13C NMR (100 MHz, CDCl3) δ 167.8, 167.2, 166.8, 139.1, 134.2, 134.1, 130.9, 124.8, 123.5, 61.4, 53.3, 
42.6, 35.0, 34.0, 33.8, 31.1, 22.3, 17.8, 13.9, 13.9, 12.0;
FTIR (neat) 2954, 2869, 1731, 1409, 1274, 884, 762, 721 cm-1; 








Following the general procedure, the reaction of 29 (20.0 mg, 66.0 μmol) with 42c (185 mg, 
0.660 mmol) afforded 45e (30.0 mg, 78%) as a colorless oil; 
1H NMR (400 MHz, CDCl3)7.85 (m, 1 H),7.81 (m, 1 H),7.73 (m, 2 H), 6.03 (d, J = 8.8 Hz, 1 H), 
5.83 (ddt, J = 16.4, 10.0, 6.4 Hz, 1 H), 5.10 (m, 2 H), 4.08 (q, J = 6.8 Hz, 2 H), 4.04 (dd, J = 8.8, 8.4 Hz, 
1 H), 3.70 (s, 3 H), 3.12 (m, 2 H), 3.07 (d, J = 8.4 Hz, 1 H), 1.34 (m, 3 H), 1.21 (t, J = 6.8 Hz, 3 H), 1.07 
(d, J = 7.6 Hz, 18 H)
13C NMR (75 MHz, CDCl3)  167.7, 167.1, 166.4, 136.9, 135.2, 134.3, 134.2, 134.1, 132.4, 123.5, 116.9, 
61.5, 53.4, 42.6, 38.8, 33.9, 33.7, 17.8, 13.9, 11.9; 
FTIR (neat) 2947, 2869, 1730, 1408, 1272, 884, 755, 721, 668 cm-1; 












Following the general procedure, the reaction of 29 (20.0 mg, 66.0 μmol) with 42d (209 mg, 
0.660 mmol) afforded 45f (10.2 mg, 25%) as a yellow oil; 
1H NMR (300 MHz, CDCl3)7.83 (m, 2 H),7.75 (m, 2 H), 7.32 (m, 5 H), 6.31 (d, J = 9.2 Hz, 1 H), 
4.11 (q, J = 7.2 Hz, 2 H), 4.00 (dd, J = 9.2, 7.8 Hz, 1 H), 3.73 (s, 3 H), 3.17 (d, J = 7.8 Hz, 1 H), 1.33 
(m, 3 H), 1.23 (t, J = 7.2 Hz, 3 H), 1.02 (d, J = 6.9 Hz, 18 H)
13C NMR (75 MHz, CDCl3)  167.6, 167.1, 166.3, 140.5, 138.4, 134.3, 134.2, 134.1, 131.7, 128.0, 127.9, 
127.7, 123.6, 61.6, 53.5, 42.7, 34.1, 33.9, 17.7, 14.0, 11.9; 
FTIR (neat) 2948, 2868, 2310, 1732, 1408, 1215, 885, 759, 721 cm-1; 










Following the general procedure, the reaction of 29 (20.0 mg, 66.0 μmol) with 42e (228 mg, 
0.660 mmol) afforded 45g (12.9 mg, 30%) as a yellow oil; 
1H NMR (400 MHz, CDCl3)7.87 (m, 1 H),7.83 (m, 1 H),7.74 (m, 2 H), 7.29 (d, J = 8.8 Hz, 2 H), 
6.85 (d, J = 8.8 Hz, 2 H), 6.23 (d, J = 9.2 Hz, 1 H), 4.09 (q, J = 6.8 Hz, 2 H), 3.94 (dd, J = 9.2, 8.4 Hz, 
1 H), 3.82 (s, 3 H), 3.72 (s, 3 H), 3.16 (d, J = 8.4 Hz, 1 H), 1.32 (m, 3 H), 1.22 (t, J = 6.8 Hz, 3 H), 1.04 
(d, J = 7.6 Hz, 18 H)
13C NMR (100 MHz, CDCl3)  167.7, 167.2, 166.7, 159.3, 140.0, 134.1, 130.9, 129.9, 129.1, 124.82, 
124.83, 123.6, 113.5, 61.5, 55.3, 53.5, 42.7, 34.1, 34.0, 17.7, 14.0, 11.9; 
FTIR (neat) 2949, 2869, 1731, 1513, 1408, 1253, 1036, 885, 755, 722 cm-1; 
HRMS (FAB) m/z calcd for C35H44NO9Si (M+H)+ 650.2785 , found 650.2790. 
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endo : exo = 2 : 1  5 : 1 (R1 = H)


















































2 置換ニトロオレフィン 46 を用いてモノ置換フランとの DA 反応を試みた(Scheme 3-1)。
3)単純なアルキル置換基をもつ基質として過剰量の 2-メチルフランと室温下無溶媒で反応さ





ろ、共役付加体のみを与えた。この原因としては嵩高い TIPS 基の立体障害による 2 位の反
応性の低下、あるいは酸素原子の電子供与能による 5 位の反応性の向上によるものであると
推測している。次に 3-フランメタノールの TBS 保護体との反応を試みると DA 反応のみが
進行した。立体選択性は endo/exo= 4.5 : 1 と向上したが位置選択性は乏しかった。 
O
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O2N CO2Et
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Scheme 3-1. DA reaction of nitroolefin 46 with monosubstituted furans 
 
次に 2,5-ジ置換フランとの DA 反応を試みた(Scheme 3-2)。2,5-ジメチルフランとの反応で
は DA 反応のみが進行した。この時、原料回収がみられ反応性はやや低下した。フラン上の 1






























endo : exo = 1 : 1.8































Scheme 3-2. DA reaction of 46 with 2,5-disubstituted furans 
 
炭素炭素結合形成段階の削減による効率化を目的として、Ethylol 基を導入した 3 置換ニト
ロオレフィン 47 の DA 反応を試みた。3c)しかし、いずれのフラン 6)を用いた場合も共役付加
体のみを与えた。この原因としては立体及び電子的な要因が考えられる(後述)。 
O OTIPS
CH2Cl2, rt, 24 h








CH2Cl2, rt, 16 h



















CH2Cl2, rt, 20 h












熱条件下 DA 生成物を得ることはできなかった(Scheme 3-4)。47 は、反応性に富むシクロペン
タジエンを用いた場合も反応は進行しなかった。 
conditions B
Me2AlCl (1.0 equiv), CH2Cl2, rt, 17 h








CH2Cl2, reflux, 17 h
Toluene, reflux, 17 h
















Scheme 3-4. DA reaction using other dienes 
 
以上の結果をまとめる。フランの 2 位に置換基が存在すると共役付加体の競合が促進され








共役付加体が生成する原因について考察した。推定反応機構を Scheme 3-5 に示す。1 段階
目から共役付加が進行する経路 (Path A)と DA 反応を経て生成する経路(Path B)の 2 つが考え
られる。Path A において、中間体 A から段階的な分子内環化が起これば DA 生成物を与える。
この時、新たに形成される炭素炭素結合を構成する炭素は嵩高いシロキシ基を含む 4 級炭素
となる。故に立体障害のために環化が進行しなかったと考えられる。一方、Path B で一旦 DA
生成物が生成した場合もシロキシ基からの電子供与とニトロ基の電子求引能力が引き金とな
り、開裂が進行し中間体 A を介して共役付加体が生成したと考えられる。Ethylol 基が置換
した 3 置換ニトロオレフィン 47 の場合は 2 置換ニトロオレフィン 46 の時と比較して立体障
害による影響がさらに大きくなることで、上記の電子供与－吸引効果が強まった結果、DA 生
成物が全く観測されなかったと考えている。現在のところ、いずれの反応経路で生成してい
るかは明らかではないものの、以上の考察から DA 反応に制御する上でフランの 2 位に酸素









































3-シロキシフランによる DA 反応 
 
これまでの結果を踏まえ、2 置換ニトロオレフィン 46 と 2,5-無置換かつ 3 位に酸素官能基
を持つフランとの組み合わせで反応を試みた(Scheme 3-6)。3-シロキシフラン 8)を用いて
CH2Cl2 中室温で反応させると、期待通りすみやかに望む DA 反応が進行した。しかし、生成
物であるシリルエノールエーテル体 48 は不安定であり、室温で放置するとニトロ基の脱離
を伴って分解することがわかった。そこで、DA 反応後 One-pot で TFA 処理することにより
ケトエステル体 49 を 85%と高収率で単離することできた。49 は単一の位置異性体かつ、望










































生成物 49 の相対立体配置は、NOE 相関と既知物質との 1H NMR におけるカップリング定
数の比較によって決定した(Figure 3-1)。9)5 位の endo プロトンは 2 位のプロトンと相関があ














































































Scheme 3-7. Regio and stereoselectivity of DA reaction 
 
本生成物 49 は当初の想定化合物と比較すると、8 位の酸素官能基と 6 位、8b 位の 2 つのア

















































(Scheme 3-8)。しかし、この場合水が付加してヘミアミナール化した DA 生成物 51 に加え、




























生成物の構造及び相対立体配置は 1H NMR におけるケミカルシフト値とカップリング定数
53 
 
によって決定した。DA 生成物 51 は Figure 3-1 で述べた際と同様のカップリングパターンを
示し、望む立体化学を持つものが主生成物として得られていることがわかった(Figure 3-2)。
一方、共役付加体 52 は DA 体とは異なるスペクトルを示した。すなわち、芳香族領域( 7.25)


















 2.26 (dd, J = 14.4, 5.1 Hz)
 5.44 (dt, J = 5.1, 1.4 Hz)
 5.14 (s)






 7.25 (d, J = 2.0 Hz)
 6.69 (brs)
 5.14 (dd, J = 15.0, 9.5 Hz)
 4.73 (dd, J = 15.0, 5.0 Hz)
 4.60 (dd, J = 9.5, 5.0 Hz)
 
Figure 3-2. Determination of structure and relative stereochemistry of 51 and 52 
 
本反応はメチルエステル体 53 を用いた類似例が報告されている(Scheme 3-9)。11)しかし、得
られる生成物の構造や立体化学は著者とは異なり、ヘミアミナール体ではなくエナミン体 54
が、endo 体ではなく exo 体として、共役付加体はニトロ基の位で付加した 55 が得られてい
る。報告されている 1H NMR におけるケミカルシフト値とカップリング定数を示した(Figure 
3-3)。後述するが、著者が合成した DA 生成物 51 から誘導した化合物の X 線結晶構造解析に


































 4.7 (dd, J = 15.0, 7.0 Hz, 1 H)
(dd, J = 15.0, 4.5 Hz, 1 H)










 4.95 (d, J = 4.0 Hz)
 5.485.38 (m)
 4.02 (dd, J = 4.0, 2.5 Hz)
 5.82 (d, J = 2.0 Hz)
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acetone、MeCN を用いて反応を試みるとヘミアミナール体 51 が優先的に得られ、THF を適用
したときに最も良い結果を与えた。しかしながら、51 は不安定であり単離収率は 55%、ケト
エステル 49 への変換も 1N HCl を用いる温和な条件を適用したが 69%と中程度の収率にとど























*determined by 1HNMR spectrum




















1N HCl (1.1 eq.)










いて反応を試みた(Scheme 3-11)。ジ Boc 体 56 では DA 反応自体が進行しなかったが、Me 基
を導入したアミノフラン 57 を用いたところ共役付加体の生成を抑制でき、エナミン体 58 を
単一の生成物として得ることができた。カラムクロマトグラフィーによる精製後、一部が水






































Scheme 3-11. Improvement of yield using substituted aminofurans 
 
TLC 分析により DA 反応の進行を確認した後に反応溶液に塩酸を添加するとヘミアミナー
ル体 59 の生成が加速され、室温下ですみやかに 59 を単一の生成物として与えた(Scheme 3-









endo : exo = 10 : 1
8.4 g scale












1N HCl (1.1 eq.)

















フィン 46 と 3-シロキシフランを組み合わせることにより、位置及び立体選択的に望む DA 反





Experimental Section for Chapter 3 
 





The mixture of 3-nitropropyl acetate (810 mg, 6.10 mmol) and Amberlst A-21 (405 mg, 50 
wt%) was added ethyl glyoxalate (50% in toluene, 1.2 mL, 6.10 mmol). The mixture was stirred at room 
temperature for 20 h. The mixture was filtered to remove the catalyst. The filterate was concentrated in 
vacuo to give a crude residue, which was used in the next reaction without futher purification. The crude 
mixture was dissolve in CH2Cl2 (25 mL) and cool to −78 oC. Then MsCl (3.1 mL, 41.0 mmol) was added 
dropwise followed by Et3N (5.7 ml, 41.0 mmol). The reaction mixture was stirred for 1 h and allowed 
to warm to room temperature. Sat. NH4Cl was added to the mixture, which was extracted with CH2Cl2. 
The combined organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated to give 47 (762 mg, 61%, 2 steps) as a yellow oil; 
1H NMR (400 MHz, CDCl3) δ 7.15 (s, 1 H), 4.30 (m, 4 H), 3.34 (t, J = 6.1 Hz, 2 H), 1.99 (s, 3 H), 1.34 
(t, J = 7.1 Hz, 3 H);  
13C NMR (100 MHz, CDCl3) δ 170.4, 163.5, 159.5, 123.4, 61.8, 61.1, 52.3, 26.7, 13.8;  
FTIR (neat) 1740, 1728, 1540, 1372, 1229, 1195, 1040 cm-1;  
HRMS (CI) m/z calcd for C9H14NO6 (M+H)+ 232.0821, found 232.0822. 
 





To a solution of 3-siloxyfuran (48.0 mg, 0.200 mmol) in CH2Cl2 (2 mL) was added nitroolefin 
46 (31.9 mg, 0.220 mmol). The reaction mixture was stirred for 30 min and then TFA (46 μL, 0.600 
mmol) was added. The mixture was stirred for 2 h and concentrated in vacuo. The residue was purified 
by flash column chromatography on silica gel (hexane/AcOEt = 10 : 1) to give 49 (38.9 mg, 85%, dr = 
20 : 4 : 1) as a mixture of diastereomers; 
1H NMR (600 MHz, CDCl3) 5.66 (ddd, J = 5.7, 3.9, 1.5 Hz, 1 H), 5.38 (brt, J = 5.7 Hz, 1 H), 4.79 (s, 
1 H), 4.28 (q, J = 7.2 Hz, 2 H), 3.71 (d, J = 3.9 Hz, 1 H), 2.66 (ddt, J = 18.5, 5.7, 1.5 Hz, 1 H), 2.24 (d, 
J = 18.5 Hz, 1 H), 1.33 (t, J = 7.2 Hz, 3 H); 
13C NMR (150 MHz, CDCl3) 204.7, 168.1, 86.2, 83.2, 77.8, 62.9, 47.8, 38.7, 14.1; 
FTIR (neat) 2985, 1777, 1738, 1554, 1375, 1251, 1230, 1150, 1004, 877, 781 cm-1; 









1H NMR (600 MHz, CDCl3) 5.64 (d, J = 6.6 Hz, 1 H), 5.19 (d, J = 3.3 Hz, 1 H), 4.71 (d, J = 6.6 Hz, 
1 H), 4.28 (m, 2 H), 4.12 (brdd, J = 6.6, 3.3 Hz, 1 H), 2.66 (m, 1 H), 2.24 (d, J = 18.0 Hz, 1 H), 1.30 (t, 








To a solution of N-Boc-3-aminofuran (36.6 mg, 0.200 mmol) in THF (0.4 mL) was added 
nitroolefin 46 (31.9 mg, 0.220 mmol). The reaction mixture was stirred at room temperature for 30 min 
and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (n-
hexane/AcOEt = 10 : 1) to give 51 (18.7 mg, 27%) as yellow crystals and 52 (6.6 mg, 10%) as a colorless 
oil; 
1H NMR (400 MHz, CDCl3)  5.62 (brs, 1 H), 5.44 (dt, J = 5.1, 1.4 Hz, 1 H), 5.14 (s, 1 H), 5.03 (t, J = 
5.1 Hz, 1 H), 4.25 (m, 2 H), 3.78 (d, J = 5.1 Hz, 1 H), 2.26 (dd, J = 14.4, 5.1 Hz, 1 H), 1.64 (d, J = 14.4 
Hz, 1 H), 1.49 (s, 9 H), 1.29 (t, J = 7.1 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) 169.8, 155.4, 88.7, 87.4, 86.6, 81.8, 77.3, 62.2, 47.0, 40.4, 28.1, 14.0; 
FTIR (neat) 3366, 2981, 2937, 1727, 1550, 1508, 1370, 1251, 1160, 1096, 1001, 912, 731 cm-1; 
HRMS (CI) m/z calcd for C9H11NO6 [M−NHBoc−H]- 229.0586, found 229.0587. 
 





1H NMR (400 MHz, CDCl3) 7.25 (d, J = 2.0 Hz, 1 H), 6.69 (brs, 1 H), 6.45 (brs, 1 H), 5.14 (dd, J = 
15.0, 9.5 Hz, 1 H), 4.73 (dd, J = 15.0, 5.0 Hz, 1 H), 4.60 (dd, J = 9.5, 5.0 Hz, 1 H), 4.24 (m, 2 H), 1.50 
(s, 9 H), 1.26 (t, J = 7.1 Hz, 3 H); 




FTIR (neat) 3352, 2981, 1733, 1702, 1559, 1503, 1372, 1250, 1163, 1019, 907, 740 cm-1; 





To a solution of N-Boc-3-aminofuran (512 mg, 2.80 mmol) in CH2Cl2 (28 mL) were added 
Boc2O (624 L, 2.80 mmol) and Et3N (193 L, 2.80 mmol). The mixture was stirred at room temperature 
for 18 h, quenched with sat. NH4Cl, and extracted with AcOEt. The organic layer was washed with brine, 
dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue was purified by 
flash column chromatography on silica gel (hexane/AcOEt = 5 : 1) to give 56 (690 mg, 87%) as a 
colorless oil; 
1H NMR (300 MHz, CDCl3) 7.43 (dd, J = 1.8, 0.8 Hz, 1 H), 7.34 (t, J = 1.8 Hz, 1 H), 6.36 (dd, J = 
1.8, 0.8 Hz, 1 H), 1.47 (s, 18 H); 
13C NMR (75 MHz, CDCl3) ; 
FTIR (neat) 2977, 1739, 1705, 1383, 1363, 1269, 1233, 1149, 1122, 1055, 867, 764 cm-1; 
HRMS (ESI) m/z calcd for C14H22NO5 [M+H]+ 284.1498, found 284.1495. 
 




To a solution of sodium hydride (abt, 60% oil suspension, 960 mg, 24.0 mmol) in THF (40 
mL) was added 3-aminofuran (3.78 g, 20.0 mmol) at 0 oC under an Ar atmosphere. The reaction mixture 
was stirred for 15 min at 0 oC and then MeI (1.5 mL, 24.0 mmol) was added. The mixture was stirred at 
room temperature for 2.5 h, quenched with sat. NH4Cl at 0 oC, and extracted with Et2O. The organic 
layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. 
The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 15 : 1) to give 
57 (3.57 g, 91%) as a colorless oil; 
1H NMR (300 MHz, CDCl3) 7.53 (brs, 1 H), 7.29 (brs, 1 H), 6.54 (brs, 1 H), 3.19 (s, 3 H), 1.52 (s, 9 
H); 
13C NMR (75 MHz, CDCl3) 152.8, 141.0, 130.9, 130.1, 80.3, 77.2, 34.6, 27.8; 
FTIR (neat) 2979, 1703, 1597, 1476, 1367, 1244, 1144, 1070, 870, 762 cm-1; 










To a solution of 57 (39.4 mg, 0.200 mmol) in THF (2 mL) was added nitroolefin 46 (31.9 mg, 
0.220 mmol). The reaction mixture was stirred at room temperature for 1 h and concentrated in vacuo. 
The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 15 : 1) to give 
58 (53.4 mg, 78%) as yellow crystals and 59 (10.1 mg, 14%) as a colorless oil; 
1H NMR (300 MHz, CDCl3)  6.00 (brs, 1 H), 5.54 (dd, J = 4.7, 3.2 Hz, 1 H), 5.38 (dd, J = 4.7, 1.8 Hz, 
1 H), 5.23 (d, J = 1.8 Hz, 1 H), 4.27 (q, J = 7.2 Hz, 2 H), 3.44 (d, J = 3.2 Hz, 1 H), 3.05 (s, 3 H), 1.54 
(s, 9 H), 1.32 (t, J = 7.2 Hz, 3 H); 
13C NMR (75 MHz, CDCl3)  169.9, 153.0, 152.3, 106.3, 86.7, 83.7, 82.9, 79.7, 62.2, 49.0, 35.2, 28.3, 
14.1; 
FTIR (neat) 2980, 1738, 1711, 1604, 1550, 1370, 1246, 1150, 765 cm-1; 








To a solution of 57 (98.6 mg, 0.500 mmol) in THF (5 mL) was added nitroolefin 46 (79.8 mg, 
0.550 mmol). The reaction mixture was stirred at room temperature for 30 min and then 1N HCl (550 
μL) was added. The mixture was stirred for 30 min, dilluted with H2O, and extracted with AcOEt. The 
organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 1 : 1) 
to give 59 (167 mg, 91%) as a colorless oil; 
1H NMR (400 MHz, CDCl3)  5.38 (t, J = 5.1 Hz, 1 H), 5.23 (brs, 1 H), 5.02 (brs, 1 H), 4.24 (m, 2 H), 
3.63 (d, J = 5.1 Hz, 1 H), 2.95 (s, 3 H), 2.15 (brs, 2 H), 1.51 (s, 9 H), 1.29 (t, J = 7.2 Hz, 3 H); 
13C NMR (75 MHz, CDCl3)  169.8, 156.2, 92.6, 88.7, 86.6, 81.7, 77.2, 62.0, 46.2, 38.6, 33.8, 28.0, 
14.0; 
FTIR (neat) 3451, 2979, 1736, 1700, 1550, 1369, 1248, 1150, 1085, 759 cm-1; 




One-pot procedure for the synthesis of 





To a solution of 57 (7.23 g, 36.7 mmol) in THF (92 mL) was added nitroolefin 46 (5.86 g, 40.4 
mmol). The reaction mixture was stirred at room temperature for 30 min and then 1N HCl (40.4 mL) 
was added. The mixture was refluxed for 18 h, dilluted with H2O at room temperature, and extracted 
with AcOEt. The organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo. The residue was purified by flash column chromatography on silica gel 
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第四章 : 鍵中間体への誘導 
 
第三章で述べたケトエステル体 49 から鍵中間体への誘導を試みた。逆合成解析を示す。2
つの経路を想定し、TTX の全ての炭素骨格を満足する 61、63 を鍵中間体として設定した。不
安定なオルソ酸エステルと環状グアニジンは合成の終盤に構築することにより TTX に誘導
できると考えた。61 はアルコール体 60 に対する 11 位の C1 ユニットに相当するニトリル基
の導入に続く、酸素閉環部の開環により合成できると考えた。63 はケトン体 62 を開環した
後にケトンを足がかりとした C1 ユニットの導入により合成できるとした。8a 位の含窒素 4
級炭素はケトエステル体 49 のニトロ基を足がかりとした増炭反応により導入できるとした。
この際、オキサビシクロ[2.2.1]ヘプタン骨格の特性を生かし、β 面選択的に導入できると考え




















































(1) construction of N-containing quaternary carbon center
(2) C1 homologation





















4-1 含窒素 4 級炭素構築にむけたモデル基質による検討 
 
ビシクロ[2.2.1]ヘプタン骨格上でのニトロ基を足がかりとした増炭反応は数例報告されて




























49 のケトン基を欠落させた化合物 66 をモデル基質として設定し、ニトロオレフィン 46 か
ら計 4 段階で合成した(Scheme 4-1)。具体的には、まず 46 と無置換フランの DA 反応により
オキサビシクロ[2.2.1]ヘプタン骨格を構築した。生成物 64 は endo 体と exo 体の 2 : 1 の混合
物として得られたため、カラム精製を数回行うことにより望む endo 体を分離した。続いて接
触水素化により、オレフィンを還元後 m-CPBA を用いた酸化反応によりニトロ体 65 を得た。









1) H2, Pd/C (10 wt%)
MeOH, rt, 17 h
O2N CO2Et
O
2) m-CPBA (4.0 eq.)












dr = 2 : 1
65
 




 含窒素 4 級炭素部位には 2 炭素必要である。加えて TTX の 9,10 位は酸素官能基が置換し
ていることから、酸化段階の高い C2 ユニットの導入が理想的である。66 を用いて DBU 存在
下、様々な求電子剤との反応を試みた(Scheme 4-2)。しかしながら、C2 ユニットとして furfural, 
allyl bromide を含むいくつかの反応剤の適用を試みたがいずれもアルキル化生成物は得られ
なかった。DBU のみを使ったブランク実験において、重水素化された 67 が高収率で得られ
たことから、DBU によるプロトンの引き抜きには問題がないことがわかった。Triton B 存在
下、methyl acrylate と反応させるとマイケル付加体 68 が得られた。3)しかし、残念なことに dr 
































methyl acrylate (2.0 eq.)
Triton B (35 mol%)
tBuOH, 60 oC, 2 h, 30%





dr = 2 : 1
DBU (2.0 eq.)












Scheme 4-2. Homologation reaction of 66 
 
Tonge らは脱カルボキシル化を伴う分子内型の反応によるアリル基の導入を報告している
(Scheme 4-3、式 3)。4)そこで、本法を参考に塩基として NaOMe 存在下、allyl acetate 及び、触
媒量の Pd(PPh3)2Cl2 と PPh3 を用いて MeOH 中 50 度に加熱したところ、原料回収とともにア
リル化生成物 69 を得ることができた。5)収率には課題が残るものの、生成物は単一のジアス


















CH2Cl2, rt, 10 min
R NO2
R = H, 95% (dr = 8 : 1)










生成物の相対立体配置は 3 環性骨格を有する環状ヘミアセタール 70 に誘導できたこと、及
びその NOE 相関によって決定した(Scheme 4-4)。69 をオゾン分解した後、PPh3で処理すると
フリーの 1 級水酸基が分子内で巻き込むことにより、70 を与えた。ビシクロ[2.2.1]ヘプタン
骨格はその構造により、置換基の自由度に制約があるためにアルデヒドと水酸基が trans 配置
している場合、環状ヘミアセタールの形成は不可能であると考えられる。得られた 70 の NOE




























ビシクロ[2.2.1]ヘプタン構造を有する 66 の α 面には、3 つのアキシャル水素が存在してい

















acetate)を 2.5 等量に増やすと変換率の向上が認められた(entry 2)。次に溶媒を MeOH に固定




い Pd(OAc)2、Pd2(dba)3 を用いた際も同様に低下した(entries 4 and 5)。最も良い結果を与えた
Pd(PPh3)2Cl2 に触媒を固定し、非プロトン性極性溶媒を用いて反応を試みたところ、DMF 中
80 度に加熱すると 1 時間で原料が消失し、74%で 69 を与えた(entry 7)。塩基として DBU を用
いると 84%に収率を改善できた(entry 8)。プロトン性溶媒である EtOH や非極性溶媒である
toluene 中で加熱した場合は中程度の変換率を示したことから(entries 9 and 10)、反応を促進さ
せる上で DMF の溶媒効果が重要であることがわかった。 
 
Table 4-1. Optimization of reaction condition 







































































a allyl acetate (1.3 eq.) and NaOMe (1.3 eq.) were used.
b DBU was used instead of NaOMe.





















テル基の還元を行った(Scheme 4-5)。還元剤として 3 等量の DIBAL 存在下、0 度で反応を試






るために、この時点で 1 級アルコールの保護を試みた。TBS 基による保護を CH2Cl2中で行う
と望むモノシリルエーテル体 72 に加えジシリルエーテル体 73 の生成が競合した。これは
CH2Cl2 に対する原料の溶解性に問題があると考えた。そこで DMF を溶媒として用いたとこ

















DIBAL (3.0 eq.), CH2Cl2, 0
oC, 30 min
DIBAL (3.0 eq.), CH2Cl2, 78
oC to 0 oC, 2 h
DIBAL (3.0 eq.), CH2Cl2, 78 to 40
oC, 15 h
LiAlH4 (3.0 eq.), Et2O, 0
oC, 30 min
LiBH4 (3.0 eq.), Et2O, 0
oC, 30 min


















72 : R = H






Scheme 4-5. Synthesis of the precursor of allylation reaction 
 
含窒素 4 級炭素の構築 
 
得られた 72 に対し、先のモデルの条件を適用したところアリル基の導入に成功し、含窒素
4 級炭素を立体選択的に構築できた(Scheme 4-6)。生成物 74 の相対立体配置は数工程を経て
得られるケトン体 85 の X 線結晶構造解析により確認している(Figure 4-2)。7)85 の合成は後述
する。これより、含窒素 4 級炭素を含む 3 連続立体中心を制御するとともに TTX のシクロヘ
キサン骨格を構築することができた。 




























アルコール体 74 を共通中間体として開環反応前駆体を合成した(Scheme 4-7)。ケトン体 75
は 74 を TEMPO 酸化することで得た。田辺らの手法 8)で調製したトシレート 76 に対して
NaCN を用いて 80 度に加熱したがニトリル体は得られなかった。クラウンエーテルを添加し
たところ、18-crown-6-ether では反応は進行しなかった。15-crown-5-ether 共存下 120 度まで加
熱すると TBS 基が脱保護したアルコール体 77 がもっぱら得られた。そこで、ニトリル基を
温和に導入するために脱離基をトリフレートに切り替えた。Et3N 存在下 Tf2O を作用させる
ことでトリフラート体 78 を得た。78 に対して 15-crown-5-ether 存在下 DMF 中 50 度に加熱す
ると反応はすみやかに進行し、望むニトリル体 79 を 86%で得ることができた。これより TTX

















DMF, temp., 15 h
74 R1 = H





76 R2 = TBS
77 R2 = H
TsCl (3.0 eq)
Et3N (3.0 eq.), NMI (3.0 eq.)











15-Crown 5-ether (1.5 eq.)


















76(15%) + 77 (74%)
75
78 79








































75 に対する開環反応では不飽和ケトン体は得られず、もっぱらシロキシフラン 80 を与え
71 
 
た。一方、ニトリル体 79 に対して LHMDS 存在下 THF 中、−78 度で反応させたところ望み






















THF, 78 oC, 2 h
57%









Scheme 4-8. Ring opening reaction of oxabicyclo[2.2.1]heptane skeleton 
 
これらの反応の推定反応機構を示す(Scheme 4-9)。ケトン体 75 は反応中間体として考えら
れるシリルエーテル体 A からニトロ基に対して開裂が優先的に進行することで開環体 B が
生成し、芳香族化することで 80 が得られたと考えられる。一方、ニトリル体 79 では開環し



























































を一旦 Ac 基で保護することでアセチル体 82 を得た。次にニトロ基の還元、ノシル基で保護
を行うこでノシル体 83 を得た。83 を MeOH 中 K2CO3 で処理することでアルコール体 84 と




CH2Cl2, rt, 30 min
97%
1) Zn dust (20 eq.)
1N HCl (10 eq.)
i -PrOH, rt, 23 h
2) NsCl (2.0 eq.)
Et3N (2.4 eq.)
DMAP (0.1 eq.)






















1) Zn dust (20 eq.)
1N HCl (10 eq.)











MeOH, rt, 19 h
98%
83 R = Ac
84 R = H
2) NsCl (1.0 eq.)
Et3N (1.2 eq.)
DMAP (0.1 eq.)








アルコール体 84 に対して、Et3N 存在下 Tf2O を作用させることでトリフラート体 86 を得
た(Scheme 4-11)。86 に対して 15-crown-5-ether 存在下 DMF 中、NaCN と反応させたところ、
ニトリル体は得られず、わずかに原料が回収された。この原因として Ns 基の脱保護の競合に
よる系の複雑化が示唆された。そこでニトリル基を導入した後に、ニトロ基の還元を行うこ
ととした。ニトリル体 79 に対して、Zn 存在下酸性条件で還元することでアミン体とし、続
















DMF, 50 oC, 15 h
no products
1) Zn dust (20 eq.)
1N HCl (10 eq.)
i -PrOH, rt, 22 h
2) NsCl (3.0 eq.)
Et3N (3.3 eq.)
DMAP (0.2 eq.)

















合成したアミノケトン体 85 に対して開環反応を試みた(Table 4-2)。85 に対し Et3N 存在下
TMSOTf を作用させると室温 2 時間で原料が消費された。しかし、この場合望む開環生成物
ではなく、芳香族化したカテコール体 89が 79%収率で単一の生成物として得られた(entry 1)。
反応機構としては系中で生成したシリルエノールエーテル体 90 から開環反応が進行したの
ちに、開環体 88 から再度シリルエーテル化、アミノ基の脱離による芳香族化を経て 89 が生
成したと考えられる(Scheme 4-12)。TBSOTf を用いて反応を試みたところ、カテコール体 89
とともに開環体 88 を 33%収率で得ることができた(entry 2)。これは、中間体である 90 の安定
性の向上、あるいはカテコール部位の立体反発による不安定化に対して、嵩高い TBS 基が寄
与したものと考えている。試薬の量を減らす、もしくは−40 度で反応を行うと大幅な原料回収
が観られた(entries 3 and 4)。そこで過剰量の試薬存在下−10 度で反応を試みると 89 の生成を









































0 oC to rt
0 oC to rt








































































R = TMS, TBS
 




次にアミノニトリル体 87 に対する開環反応を試みた(Table 4-3)。LHMDS 存在下 THF 中−
78 度で反応させたところ、反応は進行しなかった(entry 1)。試薬を 9 当量用いると、原料回
収とともに望む開環生成物 91 を 18%収率で得ることができた(entry 2)。温度を 0 度に昇温す




Table 4-3. Ring opening reaction of aminonitrile 87 
LHMDS (X eq.)































開環前駆体であるケトン体 85 を合成するにあたり、先の合成経路では 2 つの課題を残し
た。すなわちケトン、エステル基の還元段階が低収率であり、ケトン基の還元に伴う保護基

























49 71 83 85
low yield
 




1 つ目の課題である還元の収率を改善する目的で、還元の前に Tsuji–Trost 反応によりアリ










































手法 12)により合成したニトロオレフィン 93 に対して DA 反応を試みた。しかしながら、共































93 94  

































Scheme 4-16. Alternative plan for the efficient route 
 
作業仮説をもとに、窒素原子にプロパノールをたらしたフラン 95 との DA 反応を試みた
ところ、望むスピロヘミアミナール体 96 を 59%で合成できた(Scheme 4-17)。これは、炭素
炭素結合形成を行うと同時に One-pot でケトン基を保護できたことを意味する。次に DIBAL
















1) Zn dust (20 eq.)
1N HCl (10 eq.)
iPrOH, rt, 17 h
2) NsCl (3.0 eq.)
Et3N (3.3 eq.)
DMAP (0.2 eq.)




































1) 1N HCl (1.1 eq.)









2) TBSCl (4.0 eq.)
imidazole (5.0 eq.)
















実験結果に基づき、Tsuji–Trost 反応を適用することにより含窒素 4 級炭素を立体選択的に構
築できた。アルコール体 74 を共通中間体としてケトン体 85、及び TTX の 11 位に相当する
C1 ユニットをもつニトリル体 87 を合成できた。これらの誘導体に対するオキサビシクロ
[2.2.1]ヘプタン骨格の開環反応により、鍵中間体 88、91 の合成に成功した。また、スピロヘ


































































Experimental Section for Chapter 4 
 




The mixture of furan (36.4 mg, 0.500 mmol) and nitroolefin 46 (79.8 mg, 0.550 mmol) was 
stirred at room temperature for 14 h. The mixture was purified by flash column chromatography on 
silica gel (hexane/AcOEt = 15 : 1) to give a mixture of 64 and its diastereomer (79.9 mg, 75%, dr = 2 : 
1). The mixture was further purified by repeating silica gel column chromatography to afford the major 
stereoisomer 64; 
1H NMR (400 MHz, CDCl3) 6.73 (dd, J = 6.0, 1.2 Hz, 1 H), 6.38 (dd, J = 6.0, 1.2 Hz, 1 H), 5.53 (dd, 
J = 5.2, 3.0 Hz, 1 H), 5.46 (dd, J = 5.2, 1.2 Hz, 1 H ), 5.33 (brd, J = 1.2 Hz, 1 H), 4.27 (q, J = 7.2 Hz, 2 
H), 3.22 (d, J = 3.0 Hz, 1 H), 1.33 (t, J = 7.2 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) 169.6, 138.7, 133.4, 84.2, 83.1, 78.8, 61.9, 48.8, 13.9; 
FTIR (neat) 2985, 1732, 1541, 1375, 1268, 1222, 1197, 1019, 903, 874, 719 cm-1; 
HRMS (ESI) m/z calcd for C9H11NNaO5 (M+Na)+ 236.0535, found 236.0530. 
 




To a solution of 64 (2.94 g, 13.8 mmol) in MeOH (138 mL) was added Pd/C (10 wt%, 294 
mg). The reaction mixture was stirred at room temperature for 17 h under H2 and filtered through a thin 
celite pad to remove Pd/C. The filtrate was concentrated in vacuo to give the corresponding amine which 
was subjected to the next step without purification. To a solution of the amine in 1,2-dichloroethane 
(100 mL) was added m-CPBA (contains ca. 25% water, 12.7 g, 55.2 mmol). The mixture was stirred at 
70 oC for 1.5 h. After removal of the solvent in vacuo, the residue was diluted with AcOEt. The 
suspension was washed 0.1N NaOH and brine, and dried over MgSO4 and filtrated. The filtrate was 
concentrated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexane/AcOEt = 20 : 1) to give 65 (1.48 g, 50%) as yellow crystals;  
1H NMR (300 MHz, CDCl3) 5.41 (ddd, J = 5.4, 3.9, 1.2 Hz, 1 H), 5.40 (t, J = 5.4 Hz, 1 H), 4.98 (d, J 
= 5.4 Hz, 1 H), 4.23 (q, J = 7.2 Hz, 2 H), 3.45 (d, J = 3.9 Hz, 1 H), 1.93 (m, 1 H), 1.80 (m, 2 H), 1.64 
(m, 1 H), 1.30 (t, J = 7.2 Hz, 3 H); 
13C NMR (75 MHz, CDCl3) 169.9, 87.4, 81.1, 77.8, 61.7, 51.5, 28.6, 23.8, 13.9; 
FTIR (neat) 2987, 1736, 1548, 1468, 1376, 1311, 1245, 1205, 1056, 1008, 924, 866 cm-1; 








To a solution of 65 (1.42 g, 6.60 mmol) in Et2O (60 mL) was added slowly 
diisobutylaluminium hydride in hexane (1.02 M solution, 12.9 mL, 13.2 mmol) at 0 oC under an Ar 
atmosphere. The mixture was stirred for 15 min, quenched with 1N HCl, and extracted with AcOEt. The 
organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 3 : 1) 
to give 66 (925 mg, 81%) as yellow crystals; 
1H NMR (400 MHz, CDCl3) 4.96 (t, J = 5.4 Hz, 1 H), 4.72 (ddd, J = 5.4, 3.9, 1.4 Hz, 1 H), 4.53 (d, J 
= 5.4 Hz, 1 H), 3.76 (dd, J = 10.2, 7.3 Hz, 1 H), 3.62 (dd, J = 10.2, 7.3 Hz, 1 H), 2.77 (dt, J = 7.3, 3.9 
Hz, 1 H), 1.90–1.63 (m, 4 H); 
13C NMR (75 MHz, CDCl3) 88.4, 80.1, 77.8, 62.9, 49.0, 28.6, 24.3; 
FTIR (neat) 3429, 2967, 2885, 1544, 1381, 1051, 923, 762 cm-1; 







To a solution of 66 (270 mg, 1.56 mmol) in DMF (8 mL) were added allyl acetate (420 μL, 
3.90 mmol), DBU (583 μL, 3.90 mmol), Pd(PPh3)2Cl2 (54.7 mg, 78.0 μmol) and PPh3 (42.0 mg, 0.160 
mmol) under an Ar atmosphere. The reaction mixture was stirred at 80 oC for 1 h, then cooled to 0 oC, 
quenched with sat. NH4Cl, and extracted with Et2O. The organic layer was washed with brine, dried 
over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue was purified by flash 
column chromatography on silica gel (hexane/AcOEt = 5 : 1) to give 69 (278 mg, 84%) as yellow 
crystals; 
1H NMR (300 MHz, CDCl3) 5.69 (ddt, J = 17.4, 10.1, 7.1 Hz, 1 H), 5.18 (dd, J = 10.1, 1.2 Hz, 1 H), 
5.17 (dd, J = 17.4, 1.2 Hz, 1 H), 4.59 (d, J = 4.5 Hz, 1 H), 4.54 (d, J = 3.3 Hz, 1 H), 3.96 (dd, J = 10.2, 
6.9 Hz, 1 H), 3.74 (dd, J = 10.2, 8.3 Hz, 1 H), 2.86 (dd, J = 14.7, 7.1 Hz, 1 H), 2.84 (dd, J = 14.7, 7.1 
Hz, 1 H), 2.73 (dd, J = 8.3, 6.9 Hz, 1 H), 1.88–1.59 (m, 4 H); 
13C NMR (75 MHz, CDCl3) 130.1, 120.1, 98.9, 80.6, 80.5, 60.2, 51.9, 38.0, 29.2, 24.3; 
FTIR (neat) 3404, 2960, 2887, 1540, 1439, 1362, 1214, 1042, 932, 870 cm-1; 










Ozone was bubbled through a solution of 69 (74.6 mg, 0.350 mmol) in CH2Cl2 (3.5 mL) at 
−78 oC for 5 min. PPh3 (183 mg, 0.700 mmol) was added to the mixture. The mixture was sttired at 
room temperature for 15 h, and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexane/AcOEt = 1 : 1) to give 70 (67.8 mg, 90%, dr = 4 : 1) as a mixture 
of diastereomers; 
1H NMR (600 MHz, CDCl3) for the major isomer: 5.09 (t, J = 5.4 Hz, 1 H), 4.47 (d, J = 5.0 Hz, 1 H), 
4.34 (d, J = 5.0 Hz,1 H), 3.87 (dd, J = 11.4, 7.1 Hz, 1 H), 3.61 (t, J = 11.4 Hz, 1 H), 3.10 (dd, J = 11.4, 
7.1 Hz, 1 H), 2.94 (dd, J = 15.9, 5.4 Hz, 1 H), 2.92 (brs, 1 H), 2.24 (dd, J = 15.9, 8.8 Hz, 1 H), 1.92–
1.54 (m, 4 H); minor isomer: 5.38 (brs, 1 H), 4.49 (d, J = 4.8 Hz, 1 H), 4.28 (d, J = 5.4 Hz, 1 H), 4.00 
(dd, J = 10.8, 6.6 Hz, 1 H), 3.46 (t, J = 10.8 Hz, 1 H), 3.35 (dd, J = 10.8, 6.6 Hz, 1 H), 2.84 (dd, J = 15.3, 
2.4 Hz, 1 H), 2.64 (brs, 1 H), 2.41 (dd, J = 15.3, 6.0 Hz, 1 H), 1.92–1.54 (m, 4 H); 
13C NMR (150 MHz, CDCl3) for the major isomer:  94.8, 89.0, 82.7, 80.2, 58.9, 46.7, 34.8, 29.0, 24.7; 
minor isomer:  91.9, 90.4, 83.1, 81.0, 61.5, 45.3, 34.5, 28.0, 25.4; 
FTIR (neat) 3395, 2990, 1538, 1364, 1232, 1113, 1038, 1020, 886, 762, cm-1; 








To a solution of 49 (7.10 g, 31.0 mmol) in Et2O (150 mL) was added slowly 
diisobutylaluminium hydride in hexane (1.02 M solution, 91 mL, 93.0 mmol) at 0 oC under an Ar 
atmosphere. The mixture was stirred for 30 min, quenched with 1N HCl, and extracted with 
AcOEt/MeOH (4 : 1). The organic layer was washed with brine, dried over MgSO4, and filtered. The 
filtrate was concentrated in vacuo. The residue was purified by flash column chromatography on silica 
gel (hexane/AcOEt = 1 : 1) to give 71 (2.05 g, 35%) as white crystals; 
1H NMR (300 MHz, CD3OD) 4.81 (t, J = 5.7 Hz, 1 H), 4.74 (ddd, J = 5.7, 4.2, 1.5 Hz, 1 H), 4.33 (ddd, 
J = 9.9, 5.1, 3.6 Hz, 1 H), 4.25 (d, J = 5.1 Hz, 1 H), 3.60 (m, 2 H), 3.43 (dt, J = 8.1, 4.2 Hz, 1 H), 2.18 
(dddd, J = 13.8, 9.9, 5.7, 1.5 Hz, 1 H), 1.28 (dd, J = 13.8, 3.6 Hz, 1 H); 
13C NMR (75 MHz, CD3OD) 89.6, 83.5, 80.1, 70.6, 63.4, 41.6, 34.1; 
FTIR (neat) 3402, 2927, 1544, 1382, 1341, 1273, 1201, 1155, 1035, 915, 779 cm-1; 
81 
 








To a solution of 71 (667 mg, 3.53 mmol) in DMF (18 mL) were added TBSCl (531 mg, 3.53 
mmol) and imidazole (288 mg, 4.23 mmol). The mixture was stirred at room temperature for 1 h, 
quenched with sat. NH4Cl, and extracted with AcOEt. The organic layer was washed with brine, dried 
over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue was purified by flash 
column chromatography on silica gel (hexane/AcOEt = 5 : 1) to give 72 (882 mg, 82%) as a colorless 
oil; 
1H NMR (300 MHz, CDCl3) 4.87 (t, J = 5.4 Hz, 1 H), 4.72 (ddd, J = 5.4, 3.9, 1.4 Hz, 1 H), 4.48 (ddd, 
J = 9.3, 5.1, 3.3 Hz, 1 H), 4.29 (d, J = 5.1 Hz, 1 H), 3.75 (dd, J = 9.3, 7.5 Hz, 1 H), 3.58 (dd, J = 9.3, 8.7 
Hz, 1 H), 3.46 (ddd, J = 8.7, 7.5, 3.9 Hz, 1 H), 2.28 (dddd, J = 15.0, 9.3, 5.4, 1.4 Hz, 1 H), 1.42 (dd, J = 
15.0, 3.3 Hz, 1 H), 0.87 (s, 9 H), 0.06 (s, 6 H); 
13C NMR (75 MHz, CDCl3) 88.4, 81.7, 78.9, 69.6, 62.9, 40.7, 33.3, 25.5, 17.8, −5.8; 
FTIR (neat) 3430, 2953, 2858, 1545, 1471, 1380, 1257, 1100, 1071, 776 cm-1; 








To a solution of 72 (561 mg, 1.85 mmol) in DMF (9 mL) were added allyl acetate (497 μL, 
4.61 mmol), DBU (690 μL, 4.61 mmol), Pd(PPh3)2Cl2 (65.2 mg, 93.0 μmol) and PPh3 (48.0 mg, 0.183 
mmol) under an Ar atmosphere. The mixture was stirred at 80 oC for 1 h, quenched with sat. NH4Cl at 
0 oC, and extracted with Et2O. The organic layer was washed with brine, dried over MgSO4, and filtered. 
The filtrate was concentrated in vacuo. The residue was purified by flash column chromatography on 
silica gel (hexane/AcOEt = 15 : 1) to give 74 (451 mg, 71%) as yellow crystals; 
1H NMR (300 MHz, CDCl3) 5.69 (ddt, J = 17.7, 9.3, 7.2 Hz, 1 H), 5.17 (dd, J = 9.3, 1.5 Hz, 1 H), 5.13 
(dd, J = 17.7, 1.5 Hz, 1 H), 4.49 (d, J = 6.0 Hz, 1 H), 4.43 (ddd, J = 9.9, 4.8, 3.6 Hz, 1 H), 4.36 (d, J = 
4.8 Hz, 1 H), 3.98 (dd, J = 9.9, 5.9 Hz, 1 H), 3.76 (dd, J = 9.9, 8.7 Hz, 1 H), 3.43 (dd, J = 8.7, 5.9 Hz, 1 
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H), 2.84 (dd, J = 14.4, 7.2 Hz, 1 H), 2.74 (dd, J = 14.4, 7.2 Hz, 1 H), 2.31 (ddd, J = 14.9, 9.9, 6.0 Hz, 1 
H), 1.46 (dd, J = 14.9, 3.6 Hz, 1 H), 0.91 (s, 9 H), 0.10 (s, 6 H); 
13C NMR (75 MHz, CDCl3) 130.8, 120.1, 98.8, 82.4, 81.1, 69.3, 60.5, 43.1, 38.2, 34.2, 25.7, 18.0, −
5.6; 
FTIR (neat) 3452, 2955, 2858, 1537, 1472, 1362, 1257, 1100, 1068, 924, 837, 776 cm-1; 









To a solution of 74 (800 mg, 2.33 mmol) in CH2Cl2 (12 mL) were added TEMPO (23.2 mg, 
0.117 mmol) and PhI(OAc)2 (1.12 g, 3.50 mmol). The reaction mixture was stirred at room temperature 
for 3.5 h and concentrated in vacuo. The residue was purified by flash column chromatography on silica 
gel (hexane/AcOEt = 20 : 1) to give 75 (731 mg, 92%) as white crystals; 
1H NMR (300 MHz, CDCl3) 5.69 (ddt, J = 17.0, 9.5, 7.2 Hz, 1 H), 5.24 (dd, J = 9.5, 1.5 Hz, 1 H), 5.20 
(dd, J = 17.0, 1.2 Hz, 1 H), 4.90 (dd, J = 5.9, 0.9 Hz, 1 H), 4.35 (s, 1 H), 4.02 (dd, J = 10.2, 6.0 Hz, 1 
H), 3.81 (dd, J = 10.2, 8.1 Hz, 1 H), 2.88 (m, 3 H), 2.67 (ddd, J = 18.8, 5.9, 1.5 Hz, 1 H), 2.41 (d, J = 
18.8 Hz, 1 H), 0.91 (s, 9 H), 0.10 (s, 6 H); 
13C NMR (75 MHz, CDCl3)  207.0, 130.1, 121.2, 97.3, 83.0, 80.0, 59.7, 47.8, 39.7, 38.5, 25.7, 18.0, −
5.5; 
FTIR (neat) 2954, 2930, 1541, 1473, 1362, 1258, 1104, 840, 778 cm-1; 
HRMS (ESI) m/z calcd for C16H28NO5Si [M+H]+ 342.1737, found 342.1734. 
 
(1R*,2R*,4R*,5R*,6S*)-5-Allyl-6-(((tert-butyldimethylsilyl)oxy)methyl)-5-nitro-7-





To a solution of 74 (39.8 mg, 0.116 mmol) in CH2Cl2 (580 μL) were added TsCl (66.3 mg, 
0.348 mmol), Et3N (50 μL, 0.348 mmol) and NMI (28 μL, 0.348 mmol). The reaction mixture was 
stirred at room temperature for 3 h, quenched with sat. NH4Cl, and extracted with AcOEt. The organic 
layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. 
The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 20 : 1) to give 
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76 (51.2 mg, 88%) as a yellow crystals; 
1H NMR (300 MHz, CDCl3) .70 (d, J = 8.3 Hz, 2 H), .50 (d, J = 8.3 Hz, 2 H), 5.65 (ddt, J = 17.0, 
9.6, 7.2 Hz, 1 H), 5.16 (d, J = 9.6 Hz, 1 H), 5.12 (dd, J = 17.0, 1.2 Hz, 1 H),  (ddd, J = 9.5, 5.6, 3.6 
Hz, 1 H), 4.49 (d, J = 5.6 Hz, 2 H), 3.89 (dd, J = 10.4, 6.6 Hz, 1 H), 3.79 (dd, J = 10.4, 6.6 Hz, 1 H), 
 (t, J = 6.6 Hz, 1 H), 2.80 (m, 2 H), 2.46 (s, 3 H), 2.27 (dddd, J = 14.9, 9.5, 5.6, 1.2 Hz, 1 H), 1.64 
(dd, J = 14.9, 3.6 Hz, 1 H), 0.90 (s, 9 H), 0.09 (s, 6 H); 
13C NMR (75 MHz, CDCl3)  145.3, 132.9, 130.5, 130.0, 127.8, 120.7, 98.4, 80.7, 80.3, 75.9, 60.3, 44.2, 
38.2, 31.4, 25.7, 21.6, 18.0, −5.6; 
FTIR (neat) 2954, 2929, 2858, 1538, 1369, 1257, 1177, 1098, 1011, 838, 777 cm-1; 
HRMS (ESI) m/z calcd for C23H36NO7Si [M+H]+ 498.1982, found 498.1984. 
 
(1R*,2R*,4R*,5R*,6S*)-5-Allyl-6-(((tert-butyldimethylsilyl)oxy)methyl)-5-nitro-7-





To a solution of 74 (100 mg, 0.290 mmol) in CH2Cl2 (2.9 mL) were added Et3N (122 μL, 0.870 
mmol) and trifluoromethanesulfonic anhydride (147 μL, 0.870 mmol) at −78 oC under an Ar atmosphere. 
The reaction mixture was stirred at −78 oC for 1 h, quenched with sat. NH4Cl, and extracted with AcOEt. 
The organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated 
in vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 30 : 
1) to give 78 (110 mg, 81%) as yellow crystals; 
1H NMR (300 MHz, CDCl3) 5.64 (ddt, J = 17.1, 10.2, 7.2 Hz, 1 H), 5.19 (m, 3 H),  (d, J = 4.4 Hz, 
1 H), 4.61 (d, J = 5.7 Hz, 1 H), 4.01 (dd, J = 9.8, 5.6 Hz, 1 H), 3.75 (t, J = 9.8 Hz, 1 H), 3.21 (dd, J = 
9.8, 5.6 Hz, 1 H), 2 (dd, J = 14.4, 7.2 Hz, 1 H), 2.74 (dd, J = 14.4, 7.2 Hz, 1 H), 2.56 (ddd, J = 15.3, 
10.2, 5.7 Hz, 1 H), 1.90 (dd, J = 15.3, 4.4 Hz, 1 H), 0.91 (s, 9 H), 0.10 (s, 6 H); 
13C NMR (75 MHz, CDCl3)  130.0, 121.2, 119.1 (q, 1JCF = 317.7 Hz), 97.9, 82.2, 80.6, 80.4, 59.7, 44.5, 
38.1, 31.6, 25.7, 18.1, −5.6; 
FTIR (neat) 2956, 2859, 1541, 1419, 1362, 1248, 1215, 1145, 995, 901, 838, 777 cm-1;  










To a solution of 78 (20.0 mg, 42.0 μmol) in DMF (420 μL) were added NaCN (3.1 mg, 63.0 
μmol) and 15-crown-5-ether (12.5 μL, 0.630 mmol) at room temperature under an Ar atmosphere. The 
reaction mixture was stirred at 50 oC for 1 h, quenched with sat. NH4Cl, and extracted with Et2O. The 
organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 30 : 1) 
to give 79 (12.7 mg, 86%) as white crystals; 
1H NMR (300 MHz, CDCl3) 5.64 (ddt, J = 17.4, 10.4, 7.2 Hz, 1 H), 5.21 (dd, J = 10.4, 0.9 Hz, 1 H), 
5.16 (dd, J = 17.4, 1.5 Hz, 1 H),  (s, 1 H), 4.73 (d, J = 4.5 Hz, 1 H), 3.93 (dd, J = 9.6, 6.0 Hz, 1 H), 
3.65 (t, J = 6.0 Hz, 1 H), 2 (m, 2 H), 2.68 (m, 2 H), 2.25 (m, 2 H), 0.91 (s, 9 H), 0.10 (s, 6 H); 
13C NMR (75 MHz, CDCl3)  130.2, 121.2, 120.1, 97.8, 83.0, 80.2, 60.1, 51.5, 37.9, 32.4, 31.5, 25.8, 
18.2, −5.5; 
FTIR (neat) 2954, 2858, 2245, 1540, 1362, 1255, 1104, 838, 777 cm-1; 
HRMS (ESI) m/z calcd for C17H28N2NaO4Si [M+Na]+ 375.1716, found 375.1714. 
 
(1R*,2R*,4R*,5R*,6S*)-5-Allyl-6-(((tert-butyldimethylsilyl)oxy)methyl)-5-nitro-7-





To a solution of 74 (1.10 g, 3.20 mmol) in CH2Cl2 (9.7 mL) were added acetic anhydride (476 
μL, 4.80 mmol), Et3N (669 μL, 4.80 mmol) and DMAP (39.1 mg, 0.320 mmol). The mixture was stirred 
at room temperature for 30 min, quenched with sat. NH4Cl, and extracted with AcOEt. The organic layer 
was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The 
residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 5 : 1) to give 82 
(1.20 g, 97%) as white crystals; 
1H NMR (300 MHz, CDCl3) 5.67 (ddt, J = 17.1, 10.2, 7.2 Hz, 1 H), 5.18 (dd, J = 10.2, 1.5 Hz, 1 H), 
5.14 (dd, J = 17.1, 1.5 Hz, 1 H), 4.99 (ddd, J = 10.4, 4.8, 3.9 Hz, 1 H), 4.60 (d, J = 4.8 Hz, 1 H), 4.54 
(d, J = 5.7 Hz, 1 H), 3.96 (dd, J = 9.9, 5.7 Hz, 1 H), 3.70 (t, J = 9.9 Hz, 1 H), 3.13 (dd, J = 9.9, 5.7 Hz, 
1 H), 2.81 (dd, J = 14.4, 7.2 Hz, 1 H), 2.71 (dd, J = 14.4, 7.2 Hz, 1 H), 2.40 (ddd, J = 15.3, 10.4, 5.7 Hz, 
1 H), 2.04 (s, 3 H), 1.62 (dd, J = 15.3, 3.9 Hz, 1 H), 0.91 (s, 9 H), 0.11 (s, 6 H); 
13C NMR (75 MHz, CDCl3) 169.8, 130.5, 120.2, 98.1, 80.5, 80.4, 71.3, 60.0, 44.5, 38.0, 31.4, 25.5, 
20.4, 17.8, −5.7; 
FTIR (neat) 2930, 2858, 1741, 1537, 1472, 1374, 1362, 1232, 1100, 1055, 837, 776 cm-1; 










To a solution of 82 (1.23 g, 3.20 mmol) in i-PrOH (60 mL) were added zinc dust (4.18 g, 64.0 
mmol) and 1N HCl (32 mL, 32.0 mmol) at 0 oC. The mixture stirred at room temperature for 18 h, 
quenched with sat. NaHCO3, and filtered. The filtrate was extracted with CH2Cl2. The organic layer was 
washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The resulting 
amine was subjected to the next step without purification.  
To a solution of the amine (1.07 g, 3.00 mmol) in CH2Cl2 (15 mL) were added nosyl chloride 
(1.99 g, 9.00 mmol), Et3N (1.38 mL, 9.90 mmol) and DMAP (36.7 mg, 0.300 mmol). The reaction 
mixture was stirred at room temperature for 19 h, quenched with sat. NH4Cl, and extracted with AcOEt. 
The organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated 
in vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 5 : 
1) to give 83 (1.52 g, 88%) as yellow crystals; 
1H NMR (400 MHz, CDCl3) 8.18 (m, 1 H), 7.93 (m, 1 H), 7.74 (m, 2 H), 5.72 (dddd, J = 17.2, 10.4, 
7.6, 6.4 Hz, 1 H), 5.67 (s, 1 H), 5.04 (dd, J = 10.4, 1.5 Hz, 1 H), 5.01 (dd, J = 17.2, 1.5 Hz, 1 H), 4.93 
(ddd, J = 10.8, 4.8, 3.8 Hz, 1 H), 4.52 (d, J = 4.8 Hz, 1 H), 4.39 (d, J = 5.8 Hz, 1 H), 4.06 (dd, J = 10.0, 
4.8 Hz, 1 H), 3.52 (t, J = 10.0 Hz, 1 H), 2.70 (dd, J = 14.6, 6.4 Hz, 1 H), 2.50 (dd, J = 10.0, 4.8 Hz, 1 
H), 2.43 (dd, J = 14.6, 7.6 Hz, 1 H), 2.19 (ddd, J = 15.2, 10.8, 5.8 Hz, 1 H), 1.91 (dd, J = 15.2, 3.8 Hz, 
1 H), 1.73 (s, 3 H), 0.88 (s, 9 H), 0.10 (s, 3 H), 0.07 (s, 3 H); 
13C NMR (100 MHz, CDCl3) 169.9, 147.6, 136.6, 133.3, 132.9, 132.4, 130.0, 125.3, 119.7, 82.5, 80.7, 
72.4, 68.2, 60.7, 47.0, 37.7, 29.7, 25.6, 20.4, 17.8, −5.6; 
FTIR (neat) 2954, 2857, 1739, 1542, 1361, 1345, 1238, 1164, 1105, 1066, 838, 778 cm-1; 








To a solution of 83 (204 mg, 0.370 mmol) in MeOH (2 mL) was added K2CO3 (51.1 mg, 0.370 
mmol). The reaction mixture was stirred at room temperature for 19 h, quenched with sat. NH4Cl, and 
extracted with AcOEt. The organic layer was washed with brine, dried over MgSO4, and filtered. The 
filtrate was concentrated in vacuo. The residue was purified by flash column chromatography on silica 
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gel (hexane/AcOEt = 5 : 1) to give 84 (185 mg, 97%) as yellow crystals; 
1H NMR (400 MHz, CDCl3) 8.18 (m, 1 H), 7.91 (m, 1 H), 7.71 (m, 2 H), 5.81 (ddt, J = 18.0, 10.0, 7.2 
Hz, 1 H), 5.60 (s, 1 H), 5.08 (dd, J = 10.0, 1.2 Hz, 1 H), 5.07 (dd, J = 18.0, 1.2 Hz, 1 H), 4.34 (d, J = 6.0 
Hz, 1 H), 4.28 (m, 2 H), 4.02 (dd, J = 9.6, 5.2 Hz, 1 H), 3.55 (t, J = 9.6 Hz, 1 H), 2.76 (dd, J = 9.6, 5.2 
Hz, 1 H), 2.70 (dd, J = 14.4, 7.2 Hz, 1 H), 2.44 (dd, J = 14.4, 7.2 Hz, 1 H), 2.09 (ddd, J = 14.6, 9.6, 6.0 
Hz, 1 H), 1.75 (dd, J = 14.6, 3.2 Hz, 1 H), 1.36 (d, J = 3.6 Hz, 1 H), 0.89 (s, 9 H), 0.09 (s, 3 H), 0.07 (s, 
3 H); 
13C NMR (100 MHz, CDCl3)  147.5, 136.5, 133.2, 132.95, 132.91, 130.2, 125.4, 119.5, 83.4, 82.6, 
70.6, 68.5, 61.1, 45.6, 38.1, 33.3, 25.8, 18.1, −5.4; 
FTIR (neat) 3401, 2955, 2857, 1541, 1360, 1342, 1257, 1164, 1105, 1063, 837, 777 cm-1; 








To a solution of 84 (130 mg, 0.250 mmol) in CH2Cl2 (2.5 mL) were added TEMPO (3.91 mg, 
25.0 μmol) and PhI(OAc)2 (161 mg, 0.500 mmol). The reaction mixture was stirred at room temperature 
for 16 h and concentrated in vacuo. The residue was purified by flash column chromatography on silica 
gel (hexane/AcOEt = 5 : 1) to give 85 (124 mg, 97%) as yellow crystals; 
1H NMR (400 MHz, CDCl3) 8.09 (m, 1 H), 7.91 (m, 1 H), 7.52 (m, 2 H), 5.76 (dddd, J = 18.4, 10.4, 
8.0, 6.0 Hz, 1 H), 5.63 (s, 1 H), 5.13 (d, J = 10.4 Hz, 1 H), 5.09 (brd, J = 18.4 Hz, 1 H), 4.78 (brd, J = 
5.8 Hz, 1 H), 4.32 (s, 1 H), 4.07 (dd, J = 9.6, 5.6 Hz, 1 H), 3.62 (t, J = 9.6 Hz, 1 H), 2.73 (dd, J = 14.6, 
6.0 Hz, 1 H), 2.59 (d, J = 17.8 Hz, 1 H), 2.50 (dd, J = 14.6, 8.0 Hz, 1 H), 2.48 (dd, J = 17.8, 5.8 Hz, 1 
H), 2.31 (dd, J = 9.6, 5.6 Hz, 1 H), 0.90 (s, 9 H), 0.10 (s, 3 H), 0.09 (s, 3 H); 
13C NMR (100 MHz, CDCl3)  208.9, 147.5, 136.0, 133.8, 133.3, 131.9, 129.5, 125.6, 120.5, 83.3, 82.0, 
67.5, 60.2, 50.9, 39.1, 38.2, 25.7, 18.1, −5.4; 
FTIR (neat) 2930, 2857, 1766, 1541, 1416, 1348, 1259, 1165, 1123, 1101, 838, 778 cm-1; 











To a solution of 84 (150 mg, 0.300 mmol) in CH2Cl2 (3.0 mL) were added Et3N (418 μL, 3.00 
mmol) and trifluoromethanesulfonic anhydride (504 μL, 3.00 mmol) at −78 oC under an Ar atmosphere. 
The reaction mixture was stirred at −40 oC for 1 h, quenched with sat. NH4Cl, and extracted with AcOEt. 
The organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated 
in vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 20 : 
1) to give 86 (140 mg, 74%) as yellow crystals; 
1H NMR (300 MHz, CDCl3) 8.13 (m, 1 H), 7.89 (m, 1 H), 7.72 (m, 2 H), 5.87 (m, 1 H), 5.49 (s, 1 H), 
5.22 (m, 2 H), 5.04 (m, 1 H),  (d, J = 5.1 Hz, 1 H), 4.44 (d, J = 5.4 Hz, 1 H), 4.16 (dd, J = 9.8, 4.7 
Hz, 1 H), 3.55 (t, J = 9.8 Hz, 1 H), 2.76 (dd, J = 14.1, 6.3 Hz, 1 H), 2 (dd, J = 9.8, 4.7 Hz, 1 H), 2.37 
(dd, J = 14.1, 8.1 Hz, 1 H), 2.28 (ddd, J = 14.4, 10.2, 5.4 Hz, 1 H), 2.12 (dd, J = 14.4, 3.3 Hz, 1 H), 0.91 
(s, 9 H), 0.14 (s, 3 H), 0.10 (s, 3 H); 
13C NMR (75 MHz, CDCl3)  147.3, 135.9, 133.7, 133.3, 132.0, 129.6, 125.7, 120.8, 118.9 (q, 1JCF = 
317.7 Hz), 83.9, 82.6, 80.6, 67.8, 60.3, 46.0, 38.2, 30.3, 25.6, 18.0, −5.5, −5.6; 
FTIR (neat) 2931, 2858, 1541, 1419, 1362, 1248, 1216, 1146, 1107, 988, 838, 776 cm-1; 
HRMS (ESI) m/z calcd for C23H33F3N2NaO9S2Si [M+Na]+ 653.1247, found 653.1247. 
 
4-(((1R*,2R*,3S*,4S*,5R*)-2-Allyl-3-(((tert-butyldimethylsilyl)oxy)methyl)-5-cyano-7-






To a solution of 79 (20.1 mg, 57.0 μmol) in i-PrOH (1.2 mL) at 0 oC were added zinc dust 
(74.5 mg, 1.14 mmol) and 1N HCl (568 μL, 0.57 mmol). The mixture was stirred at room temperature 
for 22 h, quenched with sat. NaHCO3, and filtered. The filtrate was extracted with CH2Cl2. The organic 
layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. 
The resulting amine was subjected to the next step without purification.  
To a solution of the amine (18.0 mg, 56.0 μmol) in CH2Cl2 (570 μL) were added nosyl chloride 
(36.9 mg, 0.170 mmol), Et3N (26 μL, 0.180 mmol) and DMAP (1.3 mg, 11.0 μmol). The reaction mixture 
was stirred at room temperature for 4.5 h, quenched with sat. NH4Cl, and extracted with AcOEt. The 
organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 3 : 1) 
to give 87 (14.6 mg, 50%) as a yellow oil; 
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1H NMR (300 MHz, CDCl3) 8.11 (m, 1 H), 7.92 (m, 1 H), 7.77 (m, 2 H), s5.58 (ddt, J = 
17.1, 10.2, 6.9 Hz, 1 H), 5.03 (d, J = 10.2 Hz, 1 H), 4.97 (d, J = 17.1 Hz, 1 H),  (s, 1 H), 4.58 (d, J 
= 5.1 Hz, 1 H), 3.92 (dd, J = 9.8, 5.1 Hz, 1 H), 3.47 (t, J = 9.8 Hz, 1 H), 2 (m, 2 H), 2.53 (dd, J = 
14.6, 6.9 Hz, 1 H), 2.38 (t, J = 14.6, 6.9 Hz, 1 H), 2.11 (dd, J = 9.8, 5.1 Hz, 1 H), 2.03 (m, 1 H), 0.90 (s, 
9 H), 0.09 (s, 6 H); 
13C NMR (75 MHz, CDCl3)  147.7, 136.1, 133.9, 133.4, 131.6, 129.8, 125.7, 121.4, 120.7, 82.9, 81.9, 
67.7, 60.8, 54.7, 37.3, 32.8, 30.6, 25.9, 18.2, −5.3, −5.4; 
FTIR (neat) 2954, 2929, 2858, 2243, 1542, 1360, 1259, 1165, 1104, 1009, 838, 760 cm-1; 
HRMS (ESI) m/z calcd for C23H33N3NaO6SSi [M+Na]+ 530.1757, found 530.1753. 
 
4-(((1S*,5R*,6S*)-1-Allyl-5-((tert-butyldimethylsilyl)oxy)-6-(((tert-






To a solution of 85 (20.5 mg, 40.0 μmol) in CH2Cl2 (400 μL) was added Et3N (97.2 μL, 0.290 
mmol) and TBSOTf (55.2 μL, 0.240 mmol) at −10 oC under an Ar atmosphere. The reaction mixture 
was stirred at −10 oC for 2 h. Sat. NH4Cl was added to the mixture, which was extracted with AcOEt. 
The combined organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexane/AcOEt = 15 : 1) to give 88 (15.9 mg, 65%) as white crystals; 
1H NMR (300 MHz, CDCl3)8.00 (m, 1 H), 7.84 (m, 1 H), 7.70 (m, 2 H), 6.40 (d, J = 10.4 Hz, 1 H), 
5.93 (d, J = 10.4 Hz, 1 H),5.84 (m, 1 H), 5.79 (s, 1 H), 5.28 (brd, J = 10.2 Hz, 1 H), 5.26 (dd, J = 17.4, 
1.5 Hz, 1 H), 4.36 (d, J = 3.6 Hz, 1 H), 3.94 (dd, J = 10.2, 4.2 Hz, 1 H), 3.82 (dd, J = 10.2, 6.8 Hz, 1 H), 
2.98 (dd, J = 14.1, 7.2 Hz, 1 H), 2.70 (m, 1 H), 2.55 (dd, J = 14.1, 7.2 Hz, 1 H), 0.85 (s, 18 H), 0.05 (s, 
3 H), 0.04 (s, 6 H), −0.03 (s, 3 H); 
13C NMR (100 MHz, CDCl3) δ 195.7, 148.9, 147.7, 136.0, 133.6, 133.0, 131.0, 130.6, 128.3, 125.3, 
121.8, 71.0, 61.4, 57.6, 51.5, 42.9, 25.8, 25.7, 18.2, 18.1, −4.8, −5.5, −5.6, −5.7; 
FTIR (neat) 2930, 2858, 1694, 1542, 1362, 1257, 1168, 1102, 839, 780, 765 cm-1; 
HRMS (EI) m/z calcd for C28H47N2O7SSi2 (M+H)+ 611.2643, found 611.2639. 
 
4-(((2S*,6R*)-1-Allyl-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-cyano-6-hydroxycyclohex-3-en-







To a solution of 87 (15.3 mg, 30.0 μmol) in THF (300 μL) were added LHMDS in THF (1.3 
M solution, 142 μL, 0.180 mmol) at −78 oC under an Ar atmosphere. The reaction mixture was stirred 
at −78 oC for 3 h, quenched with sat. NH4Cl, and extracted with AcOEt. The organic layer was washed 
with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue was 
purified by flash column chromatography on silica gel (hexane/AcOEt = 3 : 1) to give 91 (12.2 mg, 
78%) as a yellow oil; 
1H NMR (300 MHz, CDCl3) 8.11 (m, 1 H), 7.90 (m, 1 H), 7.76 (m, 2 H), 6.32 (m, 1 H),5.86 (m, 1 H), 
5.49 (s, 1 H), 5.26 (d, J = 10.8 Hz, 1 H), 5.25 (d, J = 16.2 Hz, 1 H), 4.21 (q, J = 6.5 Hz, 1 H), 3.70 (d, J 
= 4.8 Hz, 2 H), 3.63 (brs, 1 H), 3.16 (brs, 1 H), 2 (m, 2 H), 2.39 (m, 2 H), 0.86 (s, 9 H), 0.05 (s, 3 H), 
0.01 (s, 3 H); 
13C NMR (75 MHz, CDCl3)  147.6, 143.3, 135.8, 133.8, 133.2, 131.6, 130.0, 125.6, 121.7, 118.0, 110.7, 
67.8, 64.1, 60.6, 45.9, 35.7, 33.1, 25.7, 18.1, −5.7; 
FTIR (neat) 3325, 2929, 2858, 2221, 1541, 1421, 1361, 1257, 1165, 1090, 837, 755 cm-1; 
HRMS (ESI) m/z calcd for C23H34N3O6SSi [M+H]+ 508.1938, found 508.1936. 
 




To a solution of sodium hydride (abt. 60% oil suspension, 960 mg, 24.0 mmol) in DMF (100 
mL) was added 3-aminofuran (3.78 g, 20.0 mmol) at 0 oC under an Ar atmosphere. The reaction mixture 
was stirred for 15 min and then (3-bromopropoxy)(tert-butyl)dimethylsilane (6.05 g, 22.0 mmol) was 
added. The mixture was stirred at room temperature for 16 h, quenched with sat. NH4Cl at 0 oC, and 
extracted with Et2O. The organic layer was washed with brine, dried over MgSO4, and filtered. The 
filtrate was concentrated in vacuo. The residue was purified by flash column chromatography on silica 
gel (hexane/AcOEt = 15 : 1) to give 95a (5.39 g, 76%) as a colorless oil; 
1H NMR (300 MHz, CDCl3) 7.61 (brs, 1 H), 7.27 (brs, 1 H), 6.52 (brs, 1 H), 3.65 (m, 4 H), 1.82 (m, 
2 H), 1.50 (s, 9 H), 0.89 (s, 9 H), 0.04 (s, 6 H); 
13C NMR (75 MHz, CDCl3)  153.3, 141.4, 132.5, 129.4, 80.7, 77.2, 60.5, 45.9, 31.3, 28.3, 25.9, 18.2, 
−5.5; 
FTIR (neat) 2955, 2930, 2858, 1704, 1596, 1472, 1393, 1254, 1215, 1166, 1098, 837, 756 cm-1; 
HRMS (EI) m/z calcd for C18H33NO4Si [M]+ 355.2179, found 355.2181. 
 






To a solution of 95a (5.38 g, 15.2 mmol) in CH2Cl2 (50 mL) were added AcOH (2.61 mL, 45.6 
mmol) and TBAF (1 M solution in THF, 22.8 mL, 22.8 mmol). The reaction mixture was stirred at room 
temperature for 21 h, quenched with sat. NH4Cl, and extracted with AcOEt. The organic layer was 
washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue 
was purified by flash column chromatography on silica gel (hexane/AcOEt = 3 : 1) to give 95 (3.29 g, 
90%) as a yellow oil; 
1H NMR (300 MHz, CDCl3) 7.39 (brs, 1 H), 7.28 (brs, 1 H), 6.42 (brs, 1 H), 3.72 (t, J = 6.3 Hz, 2 H), 
3.59 (brs, 2 H), 1.76 (brs, 2 H), 1.49 (s, 9 H); 
13C NMR (75 MHz, CDCl3)  155.0, 141.7, 133.1, 128.7, 81.7, 77.2, 58.4, 44.6, 30.6, 28.2; 
FTIR (neat) 3421, 2977, 2935, 2885, 1701, 1596, 1408, 1368, 1314, 1243, 1163, 1041, 869, 766 cm-1; 









To a solution of 95 (24.1 mg, 0.100 mmol) in THF (2 mL) was added nitroolefin 46 (14.6 mg, 
0.100 mmol). The reaction mixture was stirred at room temperature for 30 min and concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 3 : 1) 
to give 96 (18.2 mg, 59%) as yellow crystals; 
1H NMR spectra of 96 showed broad signals because of a mixture of rotamers. 1H NMR spectra are 
shown in appendix. 
13C NMR (150 MHz, CDCl3)  170.4, 155.6, 95.1, 87.8, 81.0, 77.1, 61.6, 60.9, 47.2, 45.0, 44.8, 28.2, 
28.0, 24.9, 13.9; 
FTIR (neat) 3018, 2978, 1737, 1715, 1551, 1369, 1253, 1216, 1151, 763, 670 cm-1; 







To a solution of 96 (25.4 mg, 65.0 μmol) in Et2O (650 μL) was added slowly 
diisobutylaluminium hydride in hexane (1.02 M solution, 131 mL, 0.130 mmol) at 0 oC under an Ar 
atmosphere. The mixture was stirred for 2 h, quenched with 1N HCl, and extracted with AcOEt. The 
organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 1 : 1) 
to give 97 (16.5 mg, 73%) as white crystals; 
1H NMR spectra of 97 showed broad signals because of a mixture of rotamers. 1H NMR spectra are 
shown in appendix. 
13C NMR (100 MHz, CDCl3) 86.7, 81.3, 75.9, 62.6, 60.6, 60.1, 44.6, 43.0, 27.9, 24.9, 
13.8; 
FTIR (neat) 3446, 2974, 1705, 1546, 1368, 1251, 1228, 1151, 1058, 1006, 856, 760 cm-1; 










To a solution of 97 (240 mg, 0.700 mmol) in CH2Cl2 (7 mL) were added TBSCl (263 mg, 1.75 
mmol) and imidazole (143 mg, 2.10 mmol). The mixture was stirred at room temperature for 1 h, 
quenched with sat. NH4Cl, and extracted with AcOEt. The organic layer was washed with brine, dried 
over MgSO4, and filtered. The filtrate was concentrated in vacuo. The residue was purified by flash 
column chromatography on silica gel (hexane/AcOEt = 3 : 1) to give 98 (287 mg, 90%) as white crystals; 
1H NMR spectra of 98 showed broad signals because of a mixture of rotamers. 1H NMR spectra are 
shown in appendix. 
13C NMR (75 MHz, CDCl3) 87.8, 80.8, 76.6, 63.3, 60.8, 44.7, 44.0, 28.0, 25.5, 25.0, 17.9, 
−5.64, −5.68; 
FTIR (neat) 2957, 2858, 1708, 1548, 1473, 1367, 1254, 1151, 1071, 839, 777 cm-1; 

















To a solution of 98 (287 mg, 0.627 mmol) in DMF (3 mL) were added allyl acetate (338 μL, 
3.14 mmol), DBU (469 μL, 3.14 mmol), Pd(PPh3)2Cl2 (66.0 mg, 94.0 μmol) and PPh3 (49.3 mg, 0.188 
mmol) under an Ar atmosphere. The mixture was stirred at 80 oC for 1 h, quenched with sat. NH4Cl at 
0 oC, and extracted with Et2O. The organic layer was washed with brine, dried over MgSO4, and filtered. 
The filtrate was concentrated in vacuo. The residue was purified by flash column chromatography on 
silica gel (hexane/AcOEt = 10 : 1) to give 99 (261 mg, 84%) as white crystals; 
1H NMR spectra of 99 showed broad signals because of a mixture of rotamers. 1H NMR spectra are 
shown in appendix. 
13C NMR (75 MHz, CDCl3) 86.6, 80.8, 78.1, 60.8, 46.0, 44.5, 37.8, 
36.2, 28.1, 25.6, 24.9, 17.9, −5.6, −5.8; 
FTIR (neat) 2956, 2930, 2858, 1711, 1537, 1473, 1362, 1240, 1162, 1006, 839, 776 cm-1; 











To a solution of 99 (29.9 mg, 60.0 mmol) in i-PrOH (1.2 mL) at 0 oC were added zinc dust 
(78.4 mg, 1.20 mmol) and 1N HCl (600 μL, 0.600 mmol). The mixture was stirred at room temperature 
for 17 h, quenched with sat. NaHCO3, and filtered. The filtrate was extracted with CH2Cl2. The organic 
layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in vacuo. 
The resulting amine was subjected to the next step without purification.  
To a solution of the amine (26.5 mg, 57.0 μmol) in CH2Cl2 (570 μL) were added nosyl chloride 
(37.6 mg, 0.170 mmol), Et3N (26 μL, 0.190 mmol) and DMAP (1.3 mg, 11.0 μmol). The reaction mixture 
was stirred at room temperature for 23 h, quenched with sat. NH4Cl, and extracted with AcOEt. The 
organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexane/AcOEt = 3 : 1) 
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to give 100 (16.7 mg, 42%) as a yellow oil; 
1H NMR spectra of 100 showed broad signals because of a mixture of rotamers. 1H NMR spectra are 
shown in appendix. 
13C NMR (75 MHz, CDCl3) .1, 125.5, 124.8, 120.7, 98.4, 95.6, 
81.6, 80.8, 61.6, 61.2, 44.7, 38.7, 38.2, 31.7, 29.7, 28.2, 25.8, 18.1, −5.5, −5.6; 
FTIR (neat) 3356, 3013, 2929, 2857, 1710, 1542, 1363, 1257, 1166, 1059, 1003, 839, 757 cm-1; 
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用いた DA 反応によるオキサビシクロ[2.2.1]ヘプタン骨格構築の試みについて述べた。DA 生
成物を得るには至らなかったが、新規の熱的シクロプロパン化反応を見出すことができた。
本反応は無溶媒、無触媒で進行し、含窒素 4 級炭素を含む高度に官能基化されたシクロプロ
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